Annual Statements Open main menu
  1. Annual Statements
  2. » Companies
  3. » AURA SYSTEMS INC
  4. » Annual Report: 2007 (Form 10-K)

AURA SYSTEMS INC - Annual Report: 2007 (Form 10-K)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-K
 
(Mark One)
 
 þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended.................................................February 28, 2007
OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from..........................to.............................
 
Commission file number ........0-17249
 
AURA SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
95-4106894
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
2330 Utah Avenue
El Segundo, California 90245
(Address of principal executive offices)
 
Registrant's telephone number, including area code: (310) 643-5300
 
 
Former name, former address and former fiscal year, if changed since last report:
 
Name of each exchange on which registered: None
 
Securities registered pursuant to Section 12(b) of the Act: None
 
Securities registered pursuant to Section 12(g) of the Act: Common Stock
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes¨ Nox 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes¨ Nox

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No ¨
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, or a non-accelerated filer (as defined in Rule 12b-2 of the Act).
 
Large Accelerated Filer ¨
 Accelerated Filer ¨
Non-accelerated filer x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes¨ No x


APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yesx No ¨
 
On August 31, 2006 the aggregate market value of the voting stock held by non-affiliates of the Registrant was approximately $44 million. The aggregate market value has been computed by reference to the last trading price of the stock on August 31, 2006.
 
On January 31, 2008, the Registrant had 36,670,820 shares of common stock outstanding.
 
2
 
TABLE OF CONTENTS

 
  
 
    
PART I
  
 
    
 
  
ITEM 1. BUSINESS
  
5
   
ITEM 1A. RISK FACTORS
  
12
 
  
ITEM 2. PROPERTIES
  
16
 
  
ITEM 3. LEGAL PROCEEDINGS
  
16
 
  
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  
16
 
  
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
 
17
 
  
ITEM 6. SELECTED FINANCIAL DATA
  
19
 
  
 
    
PART II
  
 
    
 
  
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
  
20
   
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  
26
 
  
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
  
27
   
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
  
27
   
ITEM 9A. CONTROLS AND PROCEDURES
  
27
   
ITEM 9B. OTHER INFORMATION
  
27
         
PART III
  
 
    
 
  
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE
 
28
 
  
ITEM 11. EXECUTIVE COMPENSATION
  
30
 
  
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
  
39
 
  
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
  
41
 
  
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 
  
42
         
PART IV
  
 
    
 
  
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
  
43
 
  
 
    
 
  
SIGNATURES
  
45
 
3
 
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
This Report contains forward-looking statements within the meaning of the federal securities laws. Statements other than statements of historical fact included in this Report, including the statements under the headings “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Business” and elsewhere in this Report regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would “should,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements.. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends. 
 
Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

 
·
Our ability to generate positive cash flow from operations;
 
·
Our ability to obtain additional financing to fund our operations;
 
·
Our business development and operating development; and
 
·
Our expectations of growth in demand for our products.
 
We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.
 
References in this Report to “we”, “us”, “the Company,” “Aura” or “Aura Systems”, includes Aura Systems, Inc. and its subsidiaries.
 
WHERE YOU CAN FIND MORE INFORMATION
 
As a public company, we are required to file annual, quarterly and special reports, proxy statements and other information with the Securities and Exchange Commission (the “SEC”). You may read and copy any of our materials on file with the SEC at the SEC’s Public Reference Room at 100 F Street N.E., Washington, DC 20549. Our filings are available to the public over the Internet at the SEC’s website at http://www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the Public Reference Room. We also make available copies of our Forms 8-K, 10-K, 10-Q, Proxy Statement and Annual Report at no charge to investors through our website, http://www.aurasystems.com, as soon as reasonably practicable after filing such material with the SEC.
 
4
 
PART I
 
ITEM 1. BUSINESS
 
Introduction and History
 
We design, assemble and sell the AuraGen®, our patented mobile power generator that uses the engine of a vehicle to generate electric power. The AuraGen® delivers on-location, plug-in electricity for any end use, including industrial, commercial, recreational and military applications. The AuraGen® system consists of three primary subsystems (i) the patented axial design alternator, (ii) the electronic control unit (“ECU”) and (iii) mounting kit that is a mechanical interface between the alternator and the automobile. Compared to the traditional solutions addressing the multi-billion dollar North American mobile power market (i.e., Gensets, traditional alternators, permanent magnet alternators, dynamic and static inverters), we believe the AuraGen® provides alternating current (“AC”) power as well as simultaneous direct current (“DC”) power with greater reliability and flexibility at a lower cost to the end user. We began commercializing the AuraGen® in late 1999 as a 5,000-watt 120/240V AC machine compatible with certain Chevrolet engine models. In 2001, we added an 8,000 watt configuration and also introduced AC/DC and the Inverter Charger System (“ICS”) options. More recently we introduced a dual system that generates up to 16,000-watts of continuous power. We now have configurations available for more than 90 different engine types, including a majority of General Motors and Ford models, some Daimler Chrysler models and numerous others engine models made by International, Isuzu, Nissan, Mitsubishi, Caterpillar, Detroit Diesel, Cummins, and Freightliner. More recently, a number of boats have had the AuraGen installed for both government and recreational end-users.
 
To date, AuraGen® units have been sold in numerous industries, including recreational, utilities, telecommunications, emergency/rescue, public works, catering, oil and gas, transportation, government and the military. Our objective is to be the leading developer and supplier of fully integrated mobile electric power systems.
 
We continue to hold several patents, in addition to those related to the AuraGen®, which we believe provide the basis for economically viable products in addition to the AuraGen®, but sales of the AuraGen® currently provide substantially all our operating revenues. 
 
Aura, a Delaware corporation, was founded in 1987 and, until 1992, was primarily engaged in supplying defense related technologies to classified military programs. In 1992, we acquired the Electronic Ceramic Facility (the Ceramic Operations). This facility produced piezoelectric material that we required for our Actuated Mirror Array (“AMA”) technology. In 1996, we licensed our AMA technology to Daewoo Electronics. During the same period we acquired Delphi Electric Components (“Delphi”), which developed and built microelectronic circuits and components. In 1994, we started NewCom, Inc. (“NewCom”) to manufacture and sell computer modems, sound cards and other multimedia components. By the mid - 1990s, the Company was organized into four divisions (i) AuraSound (the “Speaker Operations”) - producing and selling audio speakers based on a new and patented magnetic design, (ii) Aura Industrial & Automotive - developing numerous automotive and industrial - related magnetic devices such as linear and rotary actuators with applications for variable valves, active suspension, actuators for many industrial machines, and the development of the AuraGen® power system, (iii) NewCom- manufacturing and selling modems and computer multimedia kits, and (iv) Aura Display- using the AMA technology to develop very large very bright display systems. By 1998, the Company had three facilities in California, a facility in New Hope, Minnesota, and facilities in Osaka, Japan, Kuala Lumpur, Malaysia, and New Delhi, India. During this period the Company was investing large amounts of capital into the development of the AuraGen®.
 
In 1997, the Company spun off NewCom as a public company, with the Company retaining approximately 60% ownership. NewCom owed the Company approximately $40 million that was due to be repaid by late 1998. In the summer of 1998, the computer industry experienced a significant slow-down and most original equipment manufacturers (“OEMs”), in order to revive their sales, introduced built - in modems and multi-media functions as an integral part of the computer. This caused severe pressure on NewCom’s operations. By early 1999, NewCom had ceased operations and closed down.
 
5
 
During 1999, the Company sold the Speaker Operations, the Ceramic Operations, and Delphi. All activities on the AMA were stopped and the Company was totally focused on the completion of the AuraGen development and commercialization
 
Since fiscal 2002, sales of the AuraGen® product have accounted for substantially all of our operating revenues.
 
During fiscal 2002 through fiscal 2005, we substantially reduced our internal staffing due to the slower-than-anticipated level of AuraGen® sales. We also suspended substantially all research and development activities. We continued to downscale our operations in fiscal 2005. However, the impact of the related cost reductions was insufficient to offset our extremely weak financial condition, which was worsened by late fees, penalties and transaction costs incident to financial defaults. In June 2005, we filed for protection under Chapter 11 of the Bankruptcy Code, and emerged on January 31, 2006 under a plan of reorganization.
 
The AuraGen®
 
The AuraGen® is composed of three basic subsystems. The first subsystem is the generator that is bolted to, and driven by, the vehicle's engine. The second subsystem is the ECU, which filters and conditions the electricity to provide clean, steady voltages for both AC and DC power. The third subsystem consists of mounting brackets and supporting components for installation and integration of the generator with the vehicle engine.
 
The AuraGen is now available in three continuous power levels, (a) 5,000 watts AC/DC, (b) 8,000 watts AC/DC and (c) 16,000 watts AC/DC.  All AC power is pure sine wave with total harmonic distortion  of less than 2.1% and is available in both 120 VAC and or 240 VAC.  In addition, the power generated on all models can be partitioned to provide simultaneous AC and 14 or 28 volts of DC or only DC, if required by the user.  The AuraGen power levels can be generated while the vehicle is being driven or parked. The VIPER (the military version of the AuraGen®system includes as an option a complete power management system which (i) monitors in real time the batteries’ voltage and temperature, (ii) provides a partition of the power between AC and DC simultaneously with the ability to be programmed from all AC to all DC, (iii) monitors the RPM of the generator, (iv) monitors the temperatures of the generator and the ECU, (iv) monitors the raw power generated, (v) monitors both the AC and DC loads as to voltage and current, (vi) provides programming of load prioritization and load shedding, and (vii) monitors the voltage of the internal 400VDC buss.
 
We provide custom engineered brackets for our models that attach to over 90 different engine and chassis models. We also provide Power Take Off (“PTO”) and hydraulic driven interfaces for bigger trucks that do not involve direct attachment to the vehicle engine.
 
Mobile Power Industry
 
The mobile power generation market is large and growing. Vehicles used in the telecommunications, utilities, public works, construction, catering, and oil and gas industries, emergency/rescue and military and recreational vehicles rely heavily on mobile power for their internal systems. In addition, mobile work sites require on-location electricity to power equipment ranging from computers to power tools.
 
Based on studies conducted by the U.S. government, Business Communications Company, Inc. and others, we estimate the annual gross North American mobile power generation market in 2008 is at least $2.5 billion and growing. Worldwide growth is expected to be fueled by increases in the development and construction of industrial infrastructures, significant growth in homeland security expenditures, and increased use of sophisticated electronic equipment in underdeveloped areas where grid-based electricity is unavailable or unreliable. We also believe that mobile power has become increasingly important as backup to electric grid power supply.
 
The traditional available solutions for mobile power users are:
 
 
·
Gensets, Gensets are standalone power generation units that are not incorporated into a vehicle and require external fuel, either gasoline or diesel, in order to generate electricity. Gensets (i) are generally noisy and cumbersome to transport because of their weight and size, (ii) typical run at constant speed to generate 50 or 60 Hz of AC power, (iii) must be operated at a significant part of the rated power to avoid wet staking, (iv) are significantly derated in the presence of harmonics in the loads and (v) require significant scheduled maintenance and service. Genset technology has been utilized since the 1950s.
 
6
 
 
·
High-Output Alternators, High-output alternators are traditionally found in trucks and commercial vehicles and the vehicle’s engine is used as the prime mover. All high-output alternators provide their rated power at very high RPM and significantly less power at lower RPM. In addition high-output alternators are generally only 30% efficient at the low RPM range and increase to 50% efficiency at the high end of the RPM range. The power generated by high-output alternators is 12 or 24 Volt DC and an inverter is required if 120 Volt AC power is needed. In addition, due to the low power output at low RPMs, in order to get significant power, a throttle controller is used to speed-up the engine.
 
 
·
Inverters, Inverters are devices that invert battery DC to AC. Inverters as mobile power generators are traditionally used in low power requirements, typically less than 2,500 watts, and do not have the ability to recharge the batteries used as the source of power. Thus, typical inverter users require other means to recharge the used batteries such as “shore-power” or gensets. More recently dynamic inverters became available. Dynamic inverters use power from the alternator to augment power from the batteries and are able to achieve power levels in excess of 6,000 watts. Dynamic inverters introduce significant stresses on both the batteries and alternators, which causes significant life shortening for both. Dynamic inverters use power from the alternator. When the inverter is turned on, the alternator is switched off from the vehicle battery and tied into a transformer that uses electronics controls to change the DC alternator inputs to AC inverter output. A separate transformer winding provides battery charging so that fully regulated 120 Volt AC and 12 Volt DC power is available as long as the engine is running at high enough RPM to provide power for the load and the battery charging. All dynamic inverters require a high-output alternator to be able to output significant AC power. As is often the case, the limiting factor is the high-output alternator. In order to get stable output, a very accurate throttle controller is also needed to maintain steady speed on the engine.
 
 
·
Permanent-Magnet Alternators. Recently a number of companies have introduced alternators using exotic permanent magnets. These alternators tend to have higher power generation capabilities than regular alternators at lower engine RPM. In order to be practical in an under-the-hood environment (200oF) active cooling must be added, since the magnets are demagnetized at approximately 176oF. There are other issues that require an active control system that will add and subtract magnetic field strength as the engine RPM increases.
 
 
·
Fuel Cells. Fuel cells are solid-state devices that produce electricity by combining a fuel containing hydrogen with oxygen. They have a wide range of applications, and can be used in place of the internal combustion engine and traditional lead-acid and lithium-ion batteries. The most widely deployed fuel cells cost about $4,500 per kilowatt.
 
 
·
Batteries. Batteries convert stored chemical energy to electrical energy.
 
Competition
 
The industry in which we operate is competitive. The primary competition for the AuraGen® is the Genset industry, and there are approximately 44 Genset manufacturers in the United States. These competitors include: Onan, Honda and Kohler.
 
There are many high-output alternator manufacturers. Some of the better known ones are Delco-Remy, Bosch, Nippon Densu, Hitachi, Mitsubishi and Prestelite.
 
There are many inverter manufacturers; some of the better-known are, Trace Engineering, Vanner, and Xentrex.
 
Most of our competitors have greater financial, technical, and marketing resources than the Company, have larger budgets for research, new product development and marketing, and have long-standing customer relationships. We also compete with many larger and more established companies in the hiring and retention of qualified personnel. In the past, our financial condition has limited our ability to market the AuraGen®.
 
7
 
The AuraGen® uses new technology and has only been available in the marketplace for a few years. As described below, because our product is radically different from traditionally available mobile power solutions, users may require lengthy evaluation periods in order to gain confidence in the product. OEMs and large fleet users also typically require considerable time to make changes to their planning and production.
 
Because of our limited financial and staff resources, we have focused our sales and marketing activities to a few industrial and military segments. In particular, we have focused on selling to the U.S. military, including the U.S. Coast Guard (the “USCG”), homeland security agencies and emergency/rescue operations, such as the Federal Emergency Management Agency.
 
More recently we expanded our focus and are now marketing to companies in the oil and gas segment, state and local governments, in particular, the Department of Transportation (“DOT”), and in the recreational boating industry.
 
Competitive Advantages of the AuraGen®
 
We believe the AuraGen® is a superior product to all of its competition due to its convenience, cost efficiency, fuel efficiency, reliability, flexibility in power output, and the quality of the electricity generated. The AuraGen® is not sensitive to temperature or altitude variations and generates the rated power at or near idle engine RPM.
 
The AuraGen® does not require scheduled maintenance and is offered with a three-year warranty, compared to the typical one-year warranty available for a Genset or inverter.
 
In addition, the AuraGen® is significantly cleaner for the environment than Gensets, the other generally available mobile power solution. The AuraGen® uses the automotive engine, which is highly regulated for environmental protection. Gensets use small engines that produce significantly higher levels of emissions per unit of power output than the automobile engine.
 
We believe that barriers to entry make it less likely that a product superior to the AuraGen® will become available in the foreseeable future. The inventions upon which the AuraGen® is based are protected by patents issued by the U.S. Patent Office. To our knowledge, there are no other patents for axial induction machines with solid rotors such as the AuraGen®.
 
Manufacturers and end users of mobile power solutions (including the military) typically require completion of extensive evaluation and approval processes before embracing new systems. After extensive testing, a number of federal, state, DOT departments, and some major industrial companies have approved the AuraGen® for purchase.
 
Thousands of AuraGen® units are currently being used for multiple applications and in all types of operating environments, providing a good sample set for reliability analysis. The results show very low failure rates, which we are reducing further via minor hardware and software modifications, better assembly procedures and improved installation training. The U.S. Army has performed its own tests and is continuing to test the AuraGen® under severe conditions. The VIPER, in use by the special forces and other combat forces, has been air-drop-certified by the U.S. Army and has been, and is, successfully deployed in Operation Enduring Freedom and Operation Iraqi Freedom.
 
The AuraGen® system passed all of the Underwriters Laboratories (“UL”) testing in 2002 and 2003. In late 2004 and early 2005, the U.S. Marine Corps successfully tested the VIPER for safety and other operational capabilities at the Aberdeen Test grounds.
 
Target Markets
 
After the Company emerged from Chapter 11 reorganization under new management, our sales and marketing activities were expanded to include the following markets.
 
Military, Homeland Security Administration and Other Federal Agencies
 
We believe the VIPER is a superior mobile power solution compared with existing alternatives for numerous military applications. The VIPER capability to produce both 120 Volt AC and 28 Volt DC power simultaneously at low engine RPM is critical for many military applications. In addition, the VIPER’s power management system, provides military users with the ability to monitor the quality and quantity of available power, the state of the on-board batteries, and the ability to prioritize different electric loads. The USCG, after three years of testing, selected the VIPER as the power system for its 190 new patrol boats; SAIC is using the VIPER on all of its VACIS gamma ray scan systems that are used for homeland and base security applications, and numerous units of special forces and regular army are using the VIPER in both Iraq and Afghanistan. The Department of Defense issued a report to Congress in August 2006, which discussed the success of the VIPER in Iraq and Afghanistan. More recently a number of military OEMs are exploring the use of the VIPER for various military programs. The Company is also pursuing marketing the VIPER for the upcoming JLTV program.
 
8
 
Marine
 
We believe that the AuraGen® is an ideal product for recreational boats with a length of 25 to 50 feet. The National Oceanic and Atmospheric Administration tested the AuraGen® on the “Magna Spirit”, a research vessel, for 3,000 miles on the open ocean and reported flawless performance. The USCG tested the VIPER for three years before choosing it to power 190 new patrol boats. The United States Navy also tested the VIPER for over 10,000 nautical miles with flawless performance. All of these organizations are leaders in the introduction of new technologies and safety for marine applications. More recently a major boat OEM successfully tested the AuraGen® on one of their production boats, and the Company is currently pursuing the required boat related certifications from UL. While the Company is not expecting any delays in getting the required certification, no assurances can be given as to when, or if, such required certification will be completed.
 
Oil and Gas Industry
 
The oil and gas industry is a heavy user of mobile power for service. We have identified a number of oil and gas service providers that require the power level, as well as the power quality, generated by the AuraGen®. In particular, there is a need for very large power to start inductive loads such as compressors, fans and electric motors. Typically the starting power required is known as lock rotor and can easily reach 30,000 watts. The AuraGen® ICS design and architecture is such that it can easily support these power levels for the very short times that are required to start the loads. We have demonstrated 30,000 watts starting power for numerous compressors and motors.
 
Mid - Size Refrigeration Trucks
 
Mid size refrigeration trucks are used throughout the country for the delivery of food. These trucks typically have a diesel engine mounted over the cab that is used as a generator for the refrigeration unit. The AuraGen® is an ideal power source that can eliminate the need for the extra diesel engine thus reducing operating cost and fuel costs. The AuraGen’s® ability to provide high wattage, start-up power is critical for this application, since a typical refrigeration system requires a two to four horsepower compressor. Such compressors require 20,000 to 30,000 watts of starting power. The Company has now sold over 100 systems for this application and is anticipating significant growth in this segment.
 
Emergency/Rescue
 
The emergency/rescue market relies heavily upon mobile power for lights, communications gear, instruments, medical equipment and digital equipment and tools. As the emergency/rescue market has undergone a transition to digital equipment and portable computers, it has experienced constant growth in mobile power needs. Approximately 20 of these organizations have started to use the AuraGen®. Recently the Red Cross has used the AuraGen® to power its communication needs in support of disaster relief during Hurricane Katrina and the wildfires in California in October 2007. In addition, hundreds of fire trucks are now using the AuraGen® as their mobile power source.
 
Facilities, Manufacturing Process and Suppliers
 
We assemble and test the AuraGen® at our 27,000 square foot facility in El Segundo, California, with components that are produced by various suppliers. Effective December 31, 2007, our current lease expired and we are currently on a month-to-month lease. In February 2008, we entered into a lease for a new facility of approximately 25,500 square feet, near our current facility. The lease is for a term of five years, commencing May 1, 2008, and carries a base rent of $28,019 per month. We feel this facility is sufficient for our current needs. We plan to expand our manufacturing and warehouse capacity during the first quarter of fiscal 2008 with a new facility in the Atlanta, Georgia area. The new facility will be no less than 50,000 square feet and will provide enough capacity to handle our projected business for the next few years. The new facility will use the experience learned over the last few years to trim the manufacturing process and to improve throughput. When the new facility comes on line our production capacity will be 24,000 units per year.
 
9
 
Early in our AuraGen® program, we determined it was most cost-effective to outsource production of components and sub-assemblies to volume-oriented manufacturers, rather than produce these parts in-house. As a result of this decision, and based on then anticipated sales, prior to fiscal 2001 we purchased, a substantial inventory of components and sub-assemblies at volume prices. Since sales did not meet our expectations, we have been assembling, testing and selling product from this inventory for several years. Many of the components and sub-assemblies are mechanical in nature, do not deteriorate, and are readily usable for all of our AuraGen® models. Some of the sub-assembly units are in the form of ECUs that have also not deteriorated and, even though there have been improvements and modifications over this period, the units in inventory required only minor applications of parts and labor to bring them to current specifications.
 
In order to renew our inventory of components, we will need to renew contracts with such manufacturers or locate other suitable manufacturers. Since February 2006, we have renewed our relationships with a number of our old suppliers and are developing relationships with others. To ensure quality and reliability in the field, we use highly qualified suppliers, the majority of which are ISO 9002 compliant.
 
Distribution and Product Support
 
We provide a turnkey product and service to support our customers in every area. We have performed all of the development, from basic physics to detailed engineering. We believe our core capabilities provide a solid foundation to resolve technical issues, develop an ongoing line of new products and continually enhance our products.
 
Our vehicle integration team develops, engineers, and supplies all of the brackets, pulleys, idlers, belts, tensioners and other components that comprise a mounting system. The group also specifies all of the requirements of the AuraGen® to allow its use with other mobile drives, such as hydraulic systems and PTO applications.
 
Research and Development
 
From fiscal 2002 through fiscal 2005 we reduced substantially all research and development activities due to our weakened financial condition. Although we believe that ongoing research and development is important to the success of our product in order to utilize the most recent technology, to develop additional products and additional uses for existing products, to stay current with changes in vehicle manufacture and design and to maintain an ongoing advantage over potential competition, our financial condition has not allowed significant expenditures on research and development, as all costs are being minimized while we seek to maintain solvency and attain profitability.
 
When we emerged from Chapter 11 reorganization, we started to rebuild our research and development team. We have introduced and started to ship our dual and Tamgen systems, which generate up to 16,000 watts of continuous power with both AC and DC simultaneous capabilities. We have completed the design and are currently testing a unit that is one third smaller than the current 5,000 and 8,000 watts system that will supply 3,000 to 4,000 watts. We are also pursuing the development of a larger unit that we expect to have 25,000 watts capability. In addition, we plan to start developing electric motors based on the AuraGen technology with the focus of this development on the ½ to 10 horsepower segment of the industry.
 
Patents and Intellectual Property
 
Our intellectual property portfolio consists of trademarks, proprietary know-how and patents.
 
In the area of electromagnetic technology, we have developed numerous magnetic systems and designs that result in a significant increase of magnetic field density per unit volume that can be converted into useful power energy or work. This increase in field density is a factor of three to four, which, when incorporated into mechanical devices, could result in a significant reduction in size and cost of production for the same performance.
 
10
 
The applications of these technological advances are in machines used every day by industrial, commercial and consumers. We have applied technology to numerous applications in industrial machines, such as generators, motors, actuators and linear motors.
 
The U.S. Patent Office awarded us 29 patents applicable to automotive and industrial applications. Of those patents, four are focused directly on the AuraGen®, seven are basic magnetic actuation, two are for control systems associated with controlling the magnetic fields in different configurations and sixteen are focused on the EVA application.
 
The sixteen (16) patents associated with the EVA application cover the implementation of a controlled magnetic field as applied to linear motors. Many of the same techniques are implemented into the AuraGen® control systems and, in particular, the control of the high power board used in the new AuraGen® inverter mode, which uses many elements from the EVA application.
 
Areas of AuraGen® Technology Innovation:
 
We hold the following patents: Nos. 5,734,217; 6,157,175; 6,700,214; 6,700,802; with expiration dates of 2015, 2017, 2019 and 2019 respectively. The above patents cover three areas, as described below.
 
Induction Machine
 
The basic patent covers a new form of induction machine with superior performance in a much smaller size than conventional machines. The solid cast rotor, the shaped magnetic field, the secondary conduction path through the steel, and the axial magnetic orientation are key components of this innovation.
 
Control System
 
This system separates the power generation from the power delivery by introducing a 400 VDC buss. For each cycle of each phase, part of the cycle power is drawn from the bus to run the electronics and energize the coils, while during the other part of the cycle, power is delivered to charge up the buss. The control system must balance all the timing to effect zero voltage change to the buss under dynamic variations of frequency and loads. The ability to optimize in real time the slip frequency is a key innovation in motor and generator control for variable speed, variable frequency, and variable load systems.
 
Bi-Directional Power Supply (“BDP”)
 
The patented ICS system developed by Aura provides a new capability in power systems. The BDP allows a system to use multiple sources of power simultaneously. It is a key component in providing the ability to deliver both AC and DC power simultaneously, as well as the ability to handle large power surges without the need for a throttle controller.
 
Employees
 
As of February 28, 2007, we employed 47 persons. We are not a party to any collective bargaining agreements.
 
Significant Customers
 
During the year ended February 28, 2007, we conducted business with two customers whose sales comprised 24% of our net sales. As of February 28, 2007, three customers accounted for 50% of our net accounts receivable.
 
During the year ended February 28, 2006, we conducted business with four customers whose sales comprised 24% of our net sales. As of February 28, 2006, two customers accounted for 87% of our net accounts receivable.
 
Backlog
 
As of January 30, 2008, we had a backlog of approximately $5.3 million. Of this amount, approximately $4.2 million is for delivery after the 2008 fiscal year Approximately $4 million of this backlog is subject to cancellation or renegotiation at the convenience of the government. We had no material backlog at the prior year corresponding date.
 
11
 
ITEM 1A. Risk Factors
 
Risk Factors Relating to Our Business
 
We have a history of losses and we may not be profitable in any future period.
 
In each fiscal year since our organization in 1987 we have not made an operating profit. We have an accumulated deficit in excess of $300 million from our inception through November 30, 2007. We cannot assure you that we will be able to achieve or maintain profitability or positive cash flow.
 
If we are unable to raise capital, our ability to implement our current business plan and ultimately our viability as a company could be adversely affected.
 
The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs. Since fiscal 2002 we have been forced to scale back operations due to inadequate working capital and in June 2005 we were forced to file for protection under Chapter 11 of the U.S. Bankruptcy Code, from which we emerged under a court-approved plan of reorganization on January 31, 2006.
 
In the past, in order to maintain liquidity we have relied upon external sources of financing, principally equity financing and private and bank indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. We are seeking to raise additional capital. However, we have no firm commitments from third parties to provide additional financing and we cannot assure you that financing will be available at the times or in the amounts required. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
 
Our revenues have declined significantly in recent years.
 
We have experienced a significant decline in operating revenues since fiscal 1998. Our net revenues peaked at approximately $104 million in the fiscal year ended February 29, 1998, prior to commercial sales of the AuraGen®. Revenues declined to $2.5 million for the fiscal year ended February, 2001. The decline in revenues was due primarily to the cessation of operations of our computer peripherals subsidiary, NewCom, in fiscal 1999, and the sale of our speaker operations, electronic component operations, and ceramics operations. Substantially all of our operating revenues are now derived from the sales of our AuraGen® products, which did not produce a material amount of revenues until the fourth quarter of our fiscal year ended February 2001. Since fiscal 2001, annual operating revenues have ranged between $1.1 million and $3.1 million.
 
Our success over the short-term depends on the commercial success of the AuraGen® products, as we are not currently engaged in any other line of business.
 
Because we have focused our business on developing a single product line, rather than on diversifying into other areas, our success in the foreseeable future will be dependent upon the commercial success of the AuraGen® product line.

We may have difficulty managing our growth.

We restructured our operation during fiscal 2004, 2005 and 2006 in order to conserve cash. Our workforce declined from 101 employees as of February 28, 2002 to 47 at February 28, 2007. We will need to hire employees, rebuild our sales and production infrastructure and improve our operating and financial systems in order to effectively manage any significant growth in demand for our products. If we do not effectively manage our growth, we will not be successful in executing our business plan, which could have a material adverse affect on our business, results of operations and financial condition.

12
 
The market acceptance of the AuraGen® is uncertain.
 
Our business is dependent upon sales generated from the AuraGen® family of products and increasing acceptance of these products. We cannot assure you that our products will achieve broad acceptance in the marketplace. The AuraGen® uses new technology and has only been available in the marketplace for a few years. Our financial condition has limited our ability to market the AuraGen® to potential customers. Because our product is radically different from traditionally available mobile power solutions, users may require lengthy evaluation periods in order to gain confidence in the product. OEMs and large fleet users also typically require considerable time to make changes to their planning and production.
 
Our business may be adversely affected by industry competition.
 
The industry in which we operate is competitive. We face substantial competition from companies that have been offering traditional solutions such as Gensets for the last 50 years, and there are more than 40 Genset manufacturers in the United States. These competitors include: Onan, Honda and Kohler.
 
Most of our competitors have greater financial resources than we do, have larger budgets for research, new product development and marketing and have long-standing customer relationships. We must compete with many larger and more established companies in the hiring and retention of qualified personnel.
 
Moreover, this market may attract new competitors that have longer operating histories, greater name recognition and significantly greater financial, technical and marketing resources than us. Our failure to meet our projections for our products’ market acceptance or the ability of our competitors to capture a first mover advantage could have a material adverse impact upon our business, operating results and financial condition. Furthermore, new product introductions or product enhancements by our current or future competitors or the use of other technologies could cause a loss of market acceptance of our products.
 
We depend on our intellectual property to provide us with a competitive advantage.
 
We rely on a number of patents and patent applications to protect the AuraGen® products from unauthorized use by competitors. Our efforts to protect our proprietary rights may not prevent infringement by others or ensure that these rights will provide us with a competitive advantage. We cannot assure you that the patents pending relating to the AuraGen® system or future patent applications will be issued or that any issued patents will not be invalidated, circumvented or challenged.
 
A portion of our proprietary technology depends upon trade secrets and unpatented technology and proprietary knowledge related to the development, promotion and operation of our products. While we generally enter into confidentiality agreements with our employees, consultants and vendors, we cannot assure you that our trade secrets and proprietary technology will not become known or be independently developed by competitors in such a manner that we have no practical recourse, and there can be no assurance that others will not develop or acquire equivalent expertise or develop products that render our current or future products noncompetitive or obsolete.
 
Litigation regarding intellectual property rights could be time-consuming and expensive and could divert our technical and management personnel from their work. We cannot assure you that such litigation expenses will not occur in the future. There also can be no assurance that other parties will not take, or threaten to take, legal action against us, alleging infringement of such parties” patents by our current or proposed products. We cannot assure you that we will have adequate financial resources to successfully institute or defend intellectual property litigation. Insurance coverage to indemnify us against liability for infringement of other parties’ intellectual property rights is either unavailable or prohibitively expensive.
 
Competition for key employees is intense, and we cannot assure you that we will be able to retain our key employees or that we will be able to attract, assimilate and retain other highly qualified personnel in the future. While we may enter into agreements with our employees regarding patents, confidentiality and related matters, we do not generally have employment agreements with our employees. The loss of key personnel, especially without notice, or the inability to hire or retain qualified personnel, particularly given our anticipated growth, could have a material adverse effect on our business, operating results and financial condition.
 
13
 
We depend on third party manufacturers for certain product components.
 
We rely extensively on subcontracts with third parties for the manufacture of most components of the AuraGen®. If these providers do not produce these products on a timely basis, if the products do not meet our specifications and quality control standards, or if the products are otherwise flawed, we may have to delay product delivery, or recall or replace unacceptable products. In addition, such failures could damage our reputation and could adversely affect our operating results. As a result, we could lose potential customers and any revenues that we may have at that time may decline dramatically.
 
Although we generally use standard industrial and electrical parts and components for our products, some of our components are currently available only from a single source or from limited sources. We may experience delays in production of the AuraGen® if we fail to identify alternate vendors or if any parts supply is interrupted or reduced, or if there is a significant increase in production costs or decline in component quality.
 
We will need to renew sources of supply to meet increases in demand for the AuraGen®.
 
We purchased the basic components for the AuraGen® units currently being sold under a bulk order placed prior to fiscal 2001. Due to sales not meeting anticipated levels, we have been selling from this inventory. In order to renew this inventory, we will need to renew contracts with such manufacturers or locate other suitable manufacturers. Although we believe that there are a number of potential manufacturers of the components, we cannot assure you that renewed contracts for components can be obtained on favorable terms. Any material adverse change in such contracts could increase our cost of goods.
 
Risks Relating to Our Common Stock

Because our operating results have been uneven and may continue to fluctuate, this could affect our stock price.

Because our efforts since 1999 have been focused entirely on the introduction of the AuraGen® family of products into the marketplace, our revenues and operating results have been uneven and may continue to be so during our current fiscal year and beyond. These fluctuations could affect our stock price. Factors which could affect our operating results include:
 
-
The size, timing and shipment of individual orders;
-
Market acceptance of our products;
-
Development of direct and indirect sales channels; and
-
The timing of introduction of new products or enhancements.
 
We have a history of filing late periodic reports with the SEC.

In June 1999, we failed to file our Annual Report on Form 10-K on the due date prescribed by the SEC, as we were unable to complete the audit of our financial statements. This in turn delayed the filing of three subsequent Quarterly Reports on Form 10-Q. The delay was occasioned by inadequate financial resources brought about by severe financial difficulties of our computer peripherals subsidiary, NewCom, which ceased operations in the first quarter of 1999. As a result of the delinquent filings, our common stock was delisted from the Nasdaq National Market in July 1999. In February 2000, we completed our financial restructuring and filed all delinquent SEC reports, and listed our common stock on the NASD, Inc. OTC Bulletin Board (the “OTCBB”). From February 2005 through the date of the filing of this report, we failed to timely file quarterly reports on Form 10-Q and Annual Reports on Form 10-K. This delay was also caused by inadequate financial resources, culminating in our filing for reorganization under Chapter 11 of the U.S. Bankruptcy Code in June 2005. As a result of our failure to file these reports we were delisted from the OTCBB in July 2005 and currently trade on the “pink sheets.” Following our emergence from bankruptcy in January 2006, we engaged auditors and other professionals to assist in the preparation of our delinquent SEC filings. As of the date of the filing of this report , all of our delinquent filings have been made and we are now eligible for re-listing on the OTCBB, subject to meeting their other requirements. However, we cannot assure you that our common stock will be listed on the OTCBB. Continued listing on the OTCBB and other U.S. exchanges requires that we timely file periodic SEC reports. Our failure to remain timely in our filings, therefore, could result in the delisting of our common stock on the OTCBB should we again become listed, which in turn could adversely affect the market liquidity of our common stock.

14

We may issue additional shares of our authorized common stock without obtaining the approval of our stockholders.

As of the date of this report, our corporate charter currently authorized our Board of Directors to issue up to 50,000,000 shares of common stock, of which 36,670,820 shares were outstanding as of January 31, 2008. The power of the Board of Directors to issue authorized shares of common stock is generally not subject to stockholder approval under Delaware state law, the state of our corporate organization. Any additional issuance of our common stock may have the effect of further diluting the equity interest of stockholders, and such dilution could be substantial.
 
Because our common stock is not traded on a national or regional market, liquidity for our common stock could be adversely impacted.

Effective July 2005, our common stock was delisted from the OTCBB. As a result, an investor may find it more difficult to dispose of or to obtain accurate price quotations and volume information concerning our common stock than if it were listed on the OTC Bulletin Board or a national or regional exchange.
 
Because our common stock is subject to rules governing low priced securities, market liquidity for our common stock could be adversely impacted.

Our common stock trades below $5.00 per share and is not listed on the Nasdaq Stock Market or a national or regional securities exchange. Therefore, our common stock is subject to the low priced security or so-called “penny stock” rules that impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors. For any transaction involving a penny stock, unless exempt, the rules require, among other things, the delivery, prior to the transaction, of a disclosure schedule required by the SEC relating to the penny stock market. These rules also require that the broker determine, based upon information obtained from the investor, that transactions in penny stocks are suitable for the investor, and require the broker to obtain the written consent of the investor prior to effecting the penny stock transaction. The broker-dealer must also disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. As long as our common stock is characterized as a penny stock, the market liquidity for these shares could be severely affected. The regulations relating to penny stocks could limit the ability of broker-dealers to sell these securities and, in turn, the ability of stockholders to sell their shares in the secondary market.
 
The potential exercise of outstanding warrants and options could adversely affect the market price of our common stock, dilute the holdings of existing stockholders and impede our ability to obtain additional equity financing.
 
As of December 31, 2007 we had outstanding 5,855,126 options and warrants to purchase our common stock at exercise prices ranging between $2.00 and $3.50, and commitments to issue an additional 2,506,050 options at exercise prices ranging between $2.00 and $3.00 upon shareholder approval of these issuances. If those option and warrant holders exercise these securities, we will be obligated to issue additional shares of common stock at the stated exercise price. As of March 3, 2008, the closing price of our common stock was $1.72per share. The existence of such rights to acquire common stock at fixed prices may prove a hindrance to our efforts to raise future equity funding, and the exercise of such rights will dilute the percentage ownership interest of our stockholders and may dilute the value of their ownership. Future sale of shares issuable on the exercise of outstanding warrants and options at fixed prices below prevailing market prices, or expectations of such sales, could adversely affect the prevailing market price of our common stock, particularly since such warrants or options may be exercised at a fixed price and resold. Further, the holders of the outstanding warrants may exercise them at a time when we would otherwise be able to obtain additional equity capital on terms more favorable to us.
 
15

We do not expect to pay dividends on our common stock in the foreseeable future.

Although our stockholders may receive dividends if, as and when declared by our Board of Directors, we do not presently intend to pay dividends on our common stock until we are able to generate revenues and profits on a sustained basis and available cash exceeds our working capital requirements. Therefore, you should not purchase our common stock if you need immediate or future income by way of dividends from your investment.
 
ITEM 2. PROPERTIES
 
Until December 2005, our majority owned subsidiary, Aura Realty, Inc. (“Aura Realty”), owned the 47,000 square foot headquarters facility and adjacent 27,690 square foot manufacturing facility in El Segundo, California that we use for production of our AuraGen® product. These properties were encumbered by a deed of trust securing a note in the original principal amount of $5.4 million, secured by our headquarters and manufacturing facilities.
 
During fiscal 2003, we sold a minority interest in Aura Realty. During fiscal 2004, we defaulted on payments under the note. Such default continued past year-end and the lender took actions regarding a possible foreclosure sale. In June 2004, we paid all arrearages, cured this default and were current on our obligations under the note as of June 30, 2005.
 
In December 2005, Aura Realty sold the two buildings to an unrelated third party. At that time we leased the smaller facility for a term of two years, and moved out of the headquarters facility. Effective December 31, 2007, our current lease expired and we are currently on a month-to-month lease. In February 2008, we entered into a lease for a new facility of approximately 25,500 square feet, near our current facility. The lease is for a term of five years, commencing May 1, 2008, and carries a base rent of $28,019 per month. We feel this facility is sufficient for our current needs.
 
ITEM 3. LEGAL PROCEEDINGS
 
Except as described below, we are not a party to any material pending legal proceedings.
 
Barovich/Chiau et. al. v. Aura Systems, Inc. et. al. (Case No. CV -95-3295).
 
As previously reported in our fiscal 2000 report on Form 10-K, we settled shareholder litigation in the referenced matter in January 1999. On November 20, 1999, the parties entered into an Amended Stipulation of Settlement, requiring that we make payment of $2,260,000 (plus interest) in thirty-six equal monthly installments of $70,350. On October 22, 2002, after we had failed to make certain monthly payments, Plaintiffs applied for and obtained a judgment against us for $935,350, representing the balance due. We have subsequently made only two monthly payments of $70,350 each, reducing the amount owed to $794,650 (plus interest) as of February 28, 2005. Subsequent to the end of fiscal 2005, the bankruptcy court in our Chapter 11 proceeding (In re Aura Systems, Inc., United States Bankruptcy Court, Central District of California, Case Number LA 05-24550-SB), approved the settlement of this claim in the amount of approximately $820,000 as an unsecured claim under our Chapter 11 Plan of Reorganization. As an unsecured claim the Plan provides for the claim to be satisfied by the issuance of approximately 465,000 shares of common stock in the reorganized company. Plaintiffs appealed the ruling of the bankruptcy court to the District Court of Appeals claiming they were a secured creditor under the Plan of Reorganization, and therefore entitled to full payment in cash over a period of five years. The appellate court upheld the ruling of the bankruptcy court, and Plaintiffs have appealed this decision to the Ninth Circuit Court of Appeals. The appeal is pending.
 
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
 
No matters were submitted to a vote of security holders in the fourth quarter of fiscal 2007.
 
16
 
PART II
 
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
 
From May 21, 1991, to July 21, 1999, our common stock was listed on the NASDAQ National Stock Market. In July 1999 the shares were de-listed from the NASDAQ National Market as a result of our failure to meet the minimum $1.00 bid price and other requirements. On February 1, 2001, our shares were listed on the OTC Bulletin Board under the symbol "AURA". In July 2005, following the filing of our Chapter 11 proceeding, our common stock ceased to be quoted on the OTC Bulletin Board. Since February 2006 our common stock has been traded on the over-the-counter market under the symbol “AUSI”.
 
Set forth below are high and low bid prices for our common stock for each quarterly period in the two most recent fiscal years. Such quotations reflect inter-dealer prices, without retail mark-up, markdown or commissions and may not necessarily represent actual transactions in the common stock. We had approximately 3,303 stockholders of record as of January 15, 2008. Stock prices for Fiscal 2006 have been adjusted to reflect the 1 for 338 reverse split effective upon our exit from bankruptcy on January 31, 2006.
 
Period
 
High
  
Low
  
Fiscal 2006
              
First Quarter ended May 31, 2005
  
$
6.76
  
$
5.07
  
Second Quarter ended August 31, 2005
  
$
5.07
  
$
0.34
  
Third Quarter ended November 30, 2005
  
$
3.72
  
$
0.68
  
Fourth Quarter ended February 28, 2006
  
$
3.38
  
$
0.68
  
 
Period
 
High
  
Low
  
Fiscal 2007
              
First Quarter ended May 31, 2006
  
$
3.25
  
$
0.55
  
Second Quarter ended August 31, 2006
  
$
0.90
  
$
0.53
  
Third Quarter ended November 30, 2006
  
$
0.80
  
$
0.75
  
Fourth Quarter ended February 28, 2007
  
$
1.63
  
$
0.65
  
 
On January 15, 2008, the reported closing sales price for our common stock was $2.28.
 
Dividend Policy
 
We have not paid any dividends on our common stock and we do not anticipate paying any dividends on our common stock in the foreseeable future. During fiscal 2004 we issued shares of Series A Convertible Redeemable Preferred Stock and in fiscal 2005 we issued Series B Preferred Stock. Under the terms of the preferred shares we could not pay dividends on our common stock until dividends had been paid on the preferred shares. Effective with the implementation of our Chapter 11 reorganization plan in January 2006 all of the outstanding shares of the Series A Preferred Stock and the Series B Preferred Stock were converted into common stock.
 
Sales of Unregistered Securities 
 
During the three months ended February 28, 2007, we sold 2,620,991 shares of our common stock to private investors for proceeds of $2,385,105.
 
All such securities were issued and sold in reliance on the exemption from registration contained in Section 4(2) of the Securities Act of 1933, and the certificates representing such securities contain a restrictive legend reflecting the limitations on future transfer of those securities. The offer and sale of these securities was made without public solicitation or advertising. The investors represented to us that they were knowledgeable and sophisticated, and were experienced in business and financial matters so as to be capable of evaluating an investment in our securities and were an “accredited investor” within the meaning of Regulation D promulgated under the Securities Act of 1933. Each of these investors was afforded full access to information regarding our business.
 
17
 
Repurchases of Equity Securities 
 
We did not repurchase any shares of our common stock during the fourth quarter of fiscal 2007.
 
Stock Performance Graph 
 
The following graph compares the cumulative total stockholder return of the Company with the cumulative total return on the NASDAQ Stock Market Index (U.S.) and the S&P Small Cap Industrial 600 Index†. The Comparisons in the graph are required by the Securities and Exchange Commission and are not intended to forecast or be indicative of possible future performance of the Company’s common stock.
 
COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN*
 
AMONG AURA SYSTEMS, INCORPORATED, THE NASDAQ STOCK MARKET (U.S.) INDEX AND THE S & P SMALL CAP INDUSTRIAL INDEX
 
 
$100 INVESTED ON 2/28/2002 IN STOCK OR INDEX-INCLUDING REINVESTMENT OF DIVIDENDS.FISCAL YEAR ENDING FEBRUARY 28
 
18
 
Cumulative Total Return and Year-to-Year Percent Return
 
   
Feb-02
Feb-03
Feb-04
Feb-05
Feb-06
Feb-07
               
AURA SYSTEMS, INC.
Cum ret
$ 100
$ 20.63
$ 18.19
$ 11.20
$ 3.36
$ 1.71
 
Y-Y %ROI
  
-79
-12
-38
-70
-49
NASDAQ STOCK MARKET INDEX (U.S.)
Cum ret
$ 100
$ 74.19
$ 112.60
$ 113.81
$ 126.55
$ 134.03
 
Y-Y %ROI
  
-26
52
1
11
6
S & P SC INDUSTRIAL 600
Cum ret
$ 100
$ 107.05
$ 85.44
$ 131.85
$ 153.69
$ 188.82
 
Y-Y %ROI
  
7
-20
54
17
23
 
† The S&P Small Cap Industrial 600 Index is a composite of stocks including many in related industries to the Company’s business. The trading symbol for the index is ^SML.
 
ITEM 6. SELECTED FINANCIAL DATA
 
The following Selected Financial Data has been taken or derived from our audited consolidated financial statements and should be read in conjunction with and is qualified in its entirety by the full-consolidated financial statements, related notes and other information included elsewhere herein.
 
AURA SYSTEMS, INC. AND SUBSIDIARIES
 
 
 
February 28, 2007
  
February 28, 2006
  
February 28, 2005
  
February 29, 2004
 
February 28, 2003
  
                                 
Net revenues
  
$
1,624,074
  
$
1,756,105
  
$
2,525,431
  
$
1,864,325
  
$
1,103,770
  
Cost of goods sold
 
$
745,060
  
$
614,327
  
$
1,573,116
  
$
934,769
  
$
571,099
  
Inventory write down
  
$
419,765
  
$
439,188
  
$
2,088,703
  
$
550,968
  
$
-
  
Gross profit (loss)
  
$
459,249
  
$
702,590
  
$
(1,136,388
 ) 
$
378,588
  
$
532,671
  
Expenses:
  
 
    
 
    
 
    
 
    
 
    
Engineering, research & development
  
$
1,048,529
  
$
1,483,247
  
$
2,482,678
  
$
2,135,061
  
$
3,956,886
  
 
  
 
 
  
$
 
  
$
 
  
$
 
  
$
 
  
Selling, general and administrative
  
$
5,200,393
  
$
5,867,388
  
$
6,061,542
  
$
7,191,925
  
$
7,374,961
  
Class action litigation & other legal settlements
  
$
-
  
$
267,726
  
$
2,765,192
  
$
-
  
$
233,259
  
Impairment losses on long-lived assets
  
$
-
  
$
-
  
$
544,510
  
$
2,000,398
  
$
2,300,000
  
Severance expense
  
$
-
  
$
-
  
$
-
  
$
-
  
$
241,243
  
Total expenses
  
$
6,248,922
  
$
7,618,361
  
$
12,678,912
  
$
11,327,384
  
$
14,106,349
  
 
                                
Loss from operations
  
$
(5,789,673
)
$
(6,915,771
)
$
(13,815,300
)
$
(10,948,796
)
$
(13,573,678
)
Other (income) and expense:
                                
Impairment of investments
  
$
-
  
$
-
  
$
286,061
  
$
500,000
  
$
818,019
  
Loss on sale of minority interest in Aura Realty
  
$
-
  
$
-
  
$
-
  
$
231,000
  
$
626,676
  
(Gain) loss on sale of investments/assets
  
$
7,750
  
$
(2,446,798
)
$
-
  
$
(201,061
)
$
-
  
Interest expense
  
$
(392,977
)
$
6,602,020
  
$
18,965,852
  
$
2,409,732
  
$
2,656,592
  
Other
  
$
6,453
  
$
(50,000
)
$
(166,345
)
$
129,337
  
$
(362,096
)
Change in derivative liability
  
$
-
  
$
16,254,502
  
$
(4,622,235
)
$
-
  
$
-
  
Provision (benefit) for taxes
  
$
-
  
$
-
  
$
-
  
$
-
  
$
-
  
Minority interest
  
$
-
  
$
-
  
$
(3,970
)
$
(365,514
)
$
14,018
  
Gain on extinguishment of debt obligations, net of income taxes
  
$
-
  
$
1,730,979
  
$
-
  
$
67,415
  
$
1,186,014
  
Preferred stock dividend
  
$
-
  
$
-
  
$
525,377
  
$
-
  
$
-
  
 
19
 
Net Income (loss)
  
$
(6,168,447
)
$
6,864,488
  
$
(28,800,040
)
$
(13,584,875
)
$
(16,140,873
)
Net loss per common share
  
$
(0.25
)
$
2.24
  
$
(22.35
)
$
(10.65
)
$
(13.52
)
Weighted average number of common shares
    
25,114,154
    
3,063,216
    
1,288,114
    
1,276,056
    
1,230,365
  
Cash/cash equivalents 
 
$
1,051,259
  
$
472,482
  
$
61,376
  
$
83,200
  
$
163,693
  
Working capital
  
$
832,744
  
$
2,567,684
  
$
(34,338,147
)
$
(14,011,245
)
$
(15,626,271
)
Total assets
 
$
5,549,137
  
$
7,891,377
  
$
13,305,777
  
$
17,760,733
  
$
23,767,866
  
Total debt
 
$
4,907,824
  
$
5,140,554
  
$
36,535,119
  
$
15,545,829
  
$
13,345,378
  
Net stockholders’ equity (deficit)
 
$
2,103,666
  
$
4,082,983
  
$
(23,883,233
)
$
(3,614,425
)
$
4,712,176
  
 
Prior period amount regarding number of shares outstanding and the price per share have been restated to give effect to a 338 for 1 reverse split which became effective upon our exit from bankruptcy on January 31, 2006.
 
PART II
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
Forward Looking Statements.
 
This Management’s Discussion and Analysis of Financial Condition and Results of Operations includes many forward-looking statements. For cautions about relying on such forward looking statements, please refer to the section entitled “Forward Looking Statements” at the beginning of this Report immediately prior to “Item 1”.
 
Overview
 
We design, assemble and sell the AuraGen®, our patented mobile power generator that uses the engine of a vehicle to generate power. The AuraGen® delivers on-location, plug-in electricity for any end use, including industrial, commercial, recreational and military applications. We began commercializing the AuraGen® in late 1999. To date, AuraGen® units have been sold in numerous industries, including recreational, utilities, telecommunications, emergency/rescue, public works, catering, oil and gas, transportation, government and the military.
 
We were founded in 1987 and, until 1992, primarily engaged in supplying defense technology to classified military programs. In 1992, we transitioned to being primarily a supplier of consumer and industrial products and services using our technology. In 1994, we founded NewCom, which manufactured and sold computer modems, sound cards and other multimedia components. In 1997, we acquired MYS Corporation of Japan (“MYS”), a manufacturer of speaker systems. NewCom ceased operations in 1999. In fiscal 2000, we sold MYS, our business divisions providing sound products, and other assets, restructured substantial indebtedness and concentrated our focus on the AuraGen® product. Since fiscal 2002 sales and support of the AuraGen® have provided substantially all of our operating revenues.
 
20
 
We have not yet achieved a level of AuraGen® sales sufficient to generate positive cash flow. Accordingly, we have depended on repeated infusions of cash in order to maintain liquidity as we have sought to develop sales. During fiscal 2002 through fiscal 2004, we substantially reduced our internal staffing due to the slower-than-anticipated level of AuraGen® sales. We also suspended substantially all research and development activities. We continued to downscale our operations in fiscal 2005 and 2006. Since emerging from Chapter 11 proceeding, we have begun to increase our research and development activities and started to increase our staff in engineering and sales.
 
In September 2004, we entered into agreements with a group of investors and holders of secured debt in order to recapitalize the Company. These agreements are referred to as the “2004 Recapitalization Transactions” or “2004 Recapitalization” and are described in more detail below under “Liquidity and Capital Resources - The 2004 Recapitalization Transactions”. Completion of the 2004 Recapitalization Transactions was intended to provide us with a more stable financial condition by infusing new capital of up to $15 million through the sale of units comprising shares of Series B Preferred Stock and common stock warrants, conversion of $3.5 million of secured debt into shares of Series B Preferred Stock and warrants, extension of the maturity of the remaining $2.1 million of secured debt to August 2005, and the settlement of legal claims with former management. However, we continued to require further financing to remain solvent. Accordingly, subsequent to the end of fiscal 2005, in June 2005 we filed for protection under Chapter 11 of the U.S. Bankruptcy Code, and emerged on January 31, 2006 under a plan of reorganization.
 
Our consolidated financial statements included in this Report have been prepared on the assumption that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
 
Our ability to continue as a going concern is dependent upon the successful achievement of profitable operations and the ability to generate sufficient cash from operations and obtain financing sources to meet our obligations. There is no assurance that such efforts will be successful.
 
Our current level of sales reflects our efforts to introduce a new product into the marketplace. Many purchases of the product are being made for evaluation purposes. We seek to achieve profitable operations by obtaining market acceptance of the AuraGen® as a competitive - superior - product providing mobile power, thereby causing sales to increase dramatically to levels which support a profitable operation. There can be no assurance that this success will be achieved.
 
Critical Accounting Policies and Estimates
 
Our management’s discussion and analysis of our financial conditions and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates, including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our consolidated financial statements.
 
Revenue Recognition 
 
We are required to make judgments based on historical experience and future expectations, as to the reliability of shipments made to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition," and related guidance. Because sales are currently in limited volume and many sales are for evaluative purposes, we have not booked a general reserve for returns. We will consider an appropriate level of reserve for product returns when our sales increase to commercial levels.
 
21
 
Inventory Valuation and Classification 
 
Inventories consist primarily of components and completed units for our AuraGen® product. Inventories are valued at the lower of cost (first-in, first-out) or market. Provision is made for estimated amounts of current inventories that will ultimately become obsolete due to changes in the product itself or vehicle engine types that go out of production. Due to continuing lower than projected sales, we are holding inventories in excess of what it expects to sell in the next fiscal year. The net inventories which are not expected to be realized within a 12-month period based on current sales forecasts have been reclassified as long term. Management believes that existing inventories can, and will, be sold in the future without significant costs to upgrade it to current models and that the valuation of the inventories, classified both as current and long-term assets, accurately reflects the realizable values of these assets. The AuraGen® product being sold currently is not technologically different from those in inventory. Existing finished goods inventories can be upgraded to the current model with only a small amount of materials and manpower. We make these assessments based on the following factors: i) existing orders, ii) age of the inventory, iii) historical experience and iv) our expectations as to future sales. If expected sales volumes do not materialize or if significant discounts from current pricing levels are granted to generate sales, there would be a material impact on our financial statements.
 
Valuation of Long-Lived Assets 
 
Long-lived assets, consisting primarily of property and equipment, and patents and trademarks, comprise a small portion of our total assets. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable. Recoverability of assets is measured by a comparison of the carrying value of an asset to the future net cash flows expected to be generated by those assets. Net cash flows are estimated based on expectations as to the realizability of the asset. Factors that could trigger a review include significant changes in the manner of an asset's use or our overall strategy.
 
Specific asset categories are treated as follows:
 
Accounts Receivable: We record an allowance for doubtful accounts based on management's expectation of collectibility of current and past due accounts receivable.
 
Property, Plant and Equipment: We depreciate our property and equipment over various useful lives ranging from five to ten years. Adjustments are made as warranted when market conditions and values indicate that the current value of an asset is less than its net book value.
 
Long-Term Investments: As we do not hold a sufficient interest in our investments to exercise significant influence and the fair market value of the investments are not readily determinable, long-term investments have been accounted for under the cost method. Management reviews financial and other available information pertaining to such investments to determine if and when a decline, other than temporary, in the value of any investment has occurred and an adjustment is warranted.
 
Patents and trademarks: As our business depends on using new technology to create new products, impairments in patents can be triggered by changed expectations regarding the foreseeable commercial production of products underlying such patents.
 
When we determine that an asset is impaired, it measures any such impairment by discounting an asset's realizable value to the present using a discount rate appropriate to the perceived risk in realizing such value. When we determine that an impaired asset has no foreseeable realizable value, it writes such asset down to zero.
 
Results of Operations
 
Our fiscal 2007 net loss was $6.2 million. In fiscal 2006, we reported net income of $6.9 million. This was primarily a result of the recording of income of $16.3 million from a change in derivative liability that essentially reversed a charge for this amount in fiscal 2005. Our fiscal 2005 net loss was $28.8 million, with $17.8 million of that loss related to non-cash charges for depreciation, amortization, asset impairments and beneficial conversion of certain debt instruments. Net operating revenues and gross profit were $1.6 million and $.5 million, respectively, in fiscal 2007, $1.8 million and $.7 million, respectively, in fiscal 2006, and $2.5 million and $(1.1) million, respectively, in fiscal 2005.
 
22
 
Revenues
 
Net revenues in fiscal 2007 decreased $132,031 to $1,624,074 from $1,756,105 in fiscal 2006, a decrease of approximately 7.5%. This slight decrease was due to the continued effects of the disruption to our business resulting from the bankruptcy proceeding and the prior reduction in the sales staff.

Net revenues in fiscal 2006 decreased $769,326 to $1,756,105 from $2,525,431 in fiscal 2005, a decrease of approximately 30%. This was due primarily to the lack of financial resources, the reduction in the workforce and the filing of bankruptcy.
 
Cost of Goods
 
Cost of goods sold in fiscal 2007 increased $130,733 to $745,060 from $614,327 in fiscal 2006. As a percentage of net revenues, cost of goods sold was 45.9% in fiscal 2007 compared to 35.2% in fiscal 2006. This was a result of the mix of products sold.

Cost of goods decreased to $614,327 in fiscal 2006 from $1,573,116 in fiscal 2005. As a percentage of costs of net revenues, cost of goods sold was 35.2% in fiscal 2006 compared to 62.3% in fiscal 2005. On the low level of sales we have had, this percentage can vary substantially from year to year based on the mix of products sold.
 
Engineering, Research and Development
 
Engineering, research and development decreased $434,718 to $1,048,529 in fiscal 2007 from $1,483,247 in fiscal 2006. The decrease is attributable to our focusing more of our efforts in the area of production. As a percentage of net revenues, engineering, research and development was 64.6% in fiscal 2007 compared to 84.5% in fiscal 2006. Research and development activities were negligible in fiscal 2007 and 2006, as we significantly reduced our research activities due to our financial condition. We expect research and development activities to begin to increase as our financial condition improves and our sales increase.
 
Engineering, research and development expense decreased $999,421to $1,483,247 in fiscal 2006 from $2,482,668 in fiscal 2005. The decrease is largely attributable to the substantial reduction in workforce that was necessitated by our financial condition and the filing of bankruptcy.
 
Selling, General and Administrative Expense
 
Selling, general and administrative expenses (“SG&A”) decreased $666,995 to $5,200,393 in fiscal 2007 from $5,867,388 in fiscal 2006. The decrease was due to a reduction in legal expense of approximately $800,000, partially offset by an increase in our workforce as we began to rebuild after exiting bankruptcy.

In fiscal 2006, SG&A decreased $1,019,154 to $5,867,388 from $6,886,542 in fiscal 2005. This decrease was primarily attributable to cost cutting efforts, including personnel reduction.
 
Legal Settlements
 
Legal settlements of $2,765,192 were recorded in fiscal 2005, primarily as a result of the settlement of litigation against us and certain of our officers by members of our former management and others as part of the 2004 Recapitalization. Approximately $1.5 million of this expense arose from valuations of the warrants, options and Series B Preferred issued as part of the settlement.
 
Asset Impairment
 
During fiscal 2005 we recorded an asset impairment charge of $544,510 for the book value of our patents due to continued low sales. There were no comparable charges in either fiscal 2007 or fiscal 2006.
 
Non-Operating Income and Expenses
 
We incurred $0.3 million of asset impairment charges in fiscal 2005. There were no comparable charges in either fiscal 2007 or fiscal 2006.
 
23
 
Net interest expense decreased to approximately $400,000 in fiscal 2007 from $6.6 million in fiscal 2006. The decrease is a result of our substantially lower debt levels when we exited bankruptcy. Net interest expense in fiscal 2006 decreased $12,363,832 to $6,602,020 from $18,965,852 in fiscal 2005. Interest expense in 2005 consisted primarily of approximately $19.2 million in charges attributable to a beneficial conversion feature of convertible notes, and warrants issued as part of the global settlement arising from the settlement of litigation.
 
We realized gains of approximately $1.7 million on extinguishment of debt in fiscal 2006 as a result of the settlement of certain debts related to our bankruptcy filing. There was no comparable item in fiscal 2007, and a negligible amount in fiscal 2005.
 
Liquidity and Capital Resources
 
At February 28, 2007, we had cash of approximately $1.05 million, compared to approximately $0.5 million at February 28, 2006. At February 28, 2007 we had working capital of approximately $800,000 as compared to approximately $2.6 million at the end of the prior fiscal year. The decrease in working capital in 2007 reflects the absence of “other receivables” at February 28, 2007, compared to $2.7 million in fiscal 2006, and an increase in current portion of notes payable from approximately $49,000 to $611,000, offset in part by a decrease in accounts payable from approximately $590,000 at February 28, 2006, to $216,000 at February 28, 2007 and increased cash at February 28, 2007.
 
Working capital of approximately $2.6 million at February 28, 2006, compared to a deficit of approximately $34 million at February 28, 2005, reflects an “other receivable” in 2006 of $2,654,864 resulting from the sale of our buildings, subscriptions receivable from the sale of stock, and the conversion of approximately $12.1 million of current liabilities into common stock and warrants under the Chapter 11 Plan of Reorganization effected on January 31, 2006 (the “Plan” or “Plan of Reorganization”).
 
At February 28, 2007, we had accounts receivable, net of allowance for doubtful accounts, of approximately $250,000 compared to approximately $88,000 at February 28, 2006, and $637,000 at February 28, 2005.
 
We acquired property and equipment at a cost of approximately $63,000 in fiscal 2007, with no spending on property and equipment in the prior fiscal year. At February 28, 2007, we had no material capital project that would require funding. We believe our current plant and equipment is sufficient to support our current level of sales. If sales increase as anticipated, we will need to expand our facilities to meet the required production levels.
 
Debt repayments of $0.1 million were made in fiscal 2007 as compared to $4.7 million in fiscal 2006. The large debt repayment in fiscal 2006 was due to the payoff of the mortgage on the buildings that were sold.
 
During the year ended February 28, 2007 $167,346 of accrued and unpaid interest was added to the principal amount of notes payable. Under the terms of the notes, no payments were required for the first twelve months, and all interest accrued during this period is added to the balance of the notes.
 
Since 2002 substantially all of our revenues from operations have been derived from sales of the AuraGen®. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs. Since fiscal 2002 we were forced to scale back operations due to inadequate working capital and in June 2005 we were forced to file for protection under Chapter 11 of the U.S. Bankruptcy Code, from which we emerged under a court-approved plan of reorganization in January 2006.
 
In the past, in order to maintain liquidity we have relied upon external sources of financing, principally equity financing and private and bank indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. We are seeking to raise additional capital. However, we have no firm commitments from third parties to provide additional financing and we cannot assure you that financing will be available at the times or in the amounts required. The issuance of additional shares of equity in connection with such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
 
24
 
Principal Capital Transactions during Fiscal 2007
 
During fiscal 2007 we issued 4,412,928 shares of common stock in private placements for net proceeds of $3,965,156.
 
Principal Capital Transactions during Fiscal 2006 - 2006 Chapter 11 Reorganization Proceeding
 
We filed for protection under Chapter 11 of the U.S. Bankruptcy Code in June 2005 as a result of acute liquidity challenges. Following commencement of our bankruptcy proceeding, we continued to rely on third party funding to cover our cash shortfalls, which included a series of secured debt financings aggregating more than $3.3 million during the pendency of our Chapter 11 proceeding and approximately $3 million raised in a private placement of common stock and warrants to a group of “new money” investors as part of the Plan of Reorganization. Through agreements reached by the Company with a group of lenders holding secured notes (“Secured Notes”) with an aggregate principal balance in excess of $6 million, and the approval of the bankruptcy court, between July and December of 2005, we concluded a series of three new secured financings, totaling $3.36 million, with three new lenders (the “DIP Lenders”).
 
We submitted a reorganization plan that was approved by the bankruptcy court and voted and approved by the DIP Lenders, the secured creditors, the unsecured creditors, the shareholders and the new money investors. The principal terms of the Plan, which became effective on January 31, 2006 (the “Effective Date”), are as follows: 
 
Secured Note Holders - The holders of the Secured Notes, with an approximate principal balance of $5.5 million immediately prior to the Effective Date, received 1,134,000 shares of Common Stock, warrants to purchase 259,900 shares of Common Stock, and restated Secured Notes with a reduced principal balance of $2,525,000 on the Effective Date, after giving effect to a $75,000 cash payment by the Company on the Effective Date. The Secured Notes, as restated, continued to be secured by substantially all of the assets of the Company, with annual interest of 7%, and payable in 48 equal monthly installments commencing 12 months after the Effective Date.

DIP Lenders - The DIP Lenders converted all of their approximately $4.06 million of loans immediately prior to the Effective Date into 6,065,699 shares of Common Stock and warrants to purchase 606,570 shares of Common Stock on the Effective Date.

Unsecured Claims - Holders of approximately $8.3 million of unsecured claims against the Company immediately prior to the Effective Date received approximately 4.7 million shares of Common and warrants to purchase 945,900 shares of Common Stock on the Effective Date in exchange for their unsecured claims.

New Money Investors - A group of new investors (“New Money Investors”) contributed a total of $3,045,000 of new money on the Effective Date in exchange for 3,349,500 shares of Common Stock and warrants to purchase 669,000 shares of Common Stock, of which approximately $1.1 million was used to pay administrative expenses of the bankruptcy proceeding outstanding on the Effective Date. An additional 837,375 shares of Common Stock were issued under the Plan following the Effective Date as the Company did not timely file a registration statement.

Series A Preferred Stockholders - The holders of the Series A Preferred Stock, of which 591,110 shares were outstanding immediately prior to the Effective Date, received a total of 357,818 shares of Common Stock and warrants to purchase 89,455 shares of Common Stock in exchange for their Series A Preferred Stock.

Series B Preferred Stockholders - The holders of $9,979,838 of Series B Preferred Stock which was fully paid for immediately prior to the Effective Date, received a total of 3,215,712 shares of Common Stock and warrants to purchase 987,195 shares of Common Stock in exchange for their Series B Preferred Stock. The remaining, unpaid shares of Series B Preferred Stock were cancelled on the Effective Date.

Common Stockholders - The holders of the 439,458,082 shares of Common Stock outstanding immediately prior to the Effective Date (“Old Common Stock”) received approximately 1.3 million shares of new Common Stock in the reorganized Company on the Effective Date in exchange for the Old Common Stock (i.e. one share of new Common Stock in exchange for each 338 shares of Old Common Stock).

Aries Group Reorganization Fee - For major contributions to the Plan, Disclosure Statement which describes the Plan, business analysis and modeling, feasibility study, assistance in settlement disputes between the Company and certain creditors, and providing valuation analysis for pricing of the investment by the New Money Investors as well as the conversion rates for the DIP Lenders, the Aries Group received 2,541,500 shares of the Company’s Common Stock and warrants to purchase 508,300 shares of Common Stock. The Plan provided that of these 2,541,500 shares of Common Stock and 508,300 warrants received by the Aries Group, 900,000 shares of Common Stock and 179,800 Warrants were to be delivered to Harry Kurtzman.
 
25
 
New Warrants -The warrants to purchase a total of approximately 3,807,319 shares of Common Stock issued under the Plan to the New Money Investors, the DIP Lenders, holders of unsecured claims, holders of Series A and Series B Preferred Stock and the Aries Group entitled the warrant holder to purchase Common Stock at a price of $3.00 per share during the first 12 months following the Effective Date, $3.50 per share during the second 12 months following the Effective Date, and $4.00 per share thereafter. The warrants to purchase a total of 259,900 shares of Common Stock issued under the Plan to the holders of the Secured Notes entitled the warrant holder to purchase Common Stock at a price of $2.00 per share during the first 12 months following the Effective Date, $2.50 per share during the second 12 months following the Effective Date, and $3.00 per share thereafter. The Plan also provided for the reservation by the Company of warrants for 500,000 shares for the Company’s management and 500,000 shares for the Company’s Board of Directors.
 
Contractual Obligations
 
The table below describes the Company’s future contractual obligations, including items not included in the consolidated balance sheet, as of February 28, 2007:
 
       
Payments Due by Period
  
Contractual Obligations 
  
 
 
Total 
  
Less Than 1 Year 
  
1-3 Years 
  
3-5 Years 
  
More Than 5 Years 
  
Long Term Debt Obligations
    
(a
)
$
2,594,529
  
$
611,411
  
$
1,358,614
  
$
624,504
  
$
0
  
Capital lease obligations
     
$
0
  
$
0
  
$
0
  
$
0
  
$
0
  
Operating leases
   
(b
)
$
175,500
  
$
175,500
  
$
0
  
$
0
  
$
0
  
Minimum license commitment
     
$
0
  
$
0
  
$
0
  
$
0
  
$
0
  
Fixed asset and inventory purchase commitments
     
$
0
  
$
0
  
$
0
  
$
0
  
$
0
  
 
                                   
Total contractual cash obligations
     
$
2,770,029
  
$
786,911
  
$
1,358,614
  
$
624,504
  
$
0
  
 
 
(a)
Represents notes payable dated January 31, 2006, bearing interest at a rate of 7% per annum and secured by substantially all of our assets. The notes carry a term of five years with interest accruing the first 12 months, principal and interest payments beginning the 13th month, and continuing through month 60. During the year ended February 28, 2007, $167,346 in accrued and unpaid interest was added to the principal balance of the notes.
 
(b)
Represents obligations for the lease of our facilities.
 
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We are exposed to various market risks, including changes in interest rates. Market risk is the potential loss arising from adverse changes in market rates and prices. We consider our exposure to market risks to be immaterial. Historically, we have not entered into derivative financial instrument transactions to manage or reduce market risk or for speculative purposes. Our long term debt obligations all bear interest at fixed rates and, therefore, have no exposure to interest rate fluctuations. Our risk related to foreign currency fluctuations is not material at this time, as any accounts we have in foreign denominations are not in themselves material.

As we anticipate needing to use the cash we held at year end within a short period, we have invested it in money market accounts, and we do not expect that the amount of fluctuation in interest rates will expose us to any significant risk due to market fluctuation.
 
26
 
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 
See Index to Consolidated Financial Statements at page F-1.
 
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
 
Not applicable.
 
ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit, is recorded, processed, summarized and reported, within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosures. Our Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures and have concluded, as of February 28, 2007, that they were not effective in view of our delinquent filings.

As of February 28, 2007, we were delinquent in filing all quarterly and annual SEC reports due since November 30, 2004. We did not have adequate financial resources to engage our outside auditors and ensure the timely filing of Form 10-K for the fiscal year ended February 28, 2005. In June 2005 our financial condition required us to seek protection from creditors under Chapter 11 of the U.S. Bankruptcy Code. The commencement of the bankruptcy proceeding placed additional demands on our then existing accounting personnel, including the filing of monthly financial reports with the bankruptcy court and the SEC. Our limited financial and personnel resources did not allow us to fully address our reporting obligations under the Securities Exchange Act of 1934 until we emerged from bankruptcy on January 31, 2006. We continued to be hampered by other events which further delayed the filing of our delinquent SEC reports. Specifically, the integrity of our financial records was severely disrupted as a result of errors made by temporary file personnel in December 2005 in the course of moving our principal office from 2335 Alaska Avenue to our Utah Avenue location. This problem was compounded by a change in accounting personnel in February 2006.

In February 2006, when we successfully emerged from bankruptcy under a plan of reorganization, we retained a new Chief Financial Officer and other accounting personnel. In May 2006we engaged new auditors to audit our financial statements for fiscal years from and after February 2005 and to review our interim quarterly financial statements for all subsequent quarters. We continue to work diligently towards the completion and filing of delinquent quarterly and annual reports. However, delays are unavoidable due to the impact of the factors discussed above and the number of financial reporting periods involved. We expect that once we become current in our SEC filings our disclosure controls and procedures will be adequate to ensure timely disclosure under SEC rules and regulations.
 
Changes in Internal Control over Financial Reporting 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended February 28, 2007, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

Not applicable.

27
 
PART III
 
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND COOPERATE GOVERNANCE
 
Directors
 
The following table sets forth our directors and executive officers, their age, and the office they hold.
 
Name
  
Age
  
Title
         
Directors
        
 
 
 
 
 
Melvin Gagerman
  
64
  
Chairman, Director, Chief Executive Officer, Chief Financial Officer and President
Arthur J. Schwartz, PhD
  
59
  
Director, Chief Technical Officer
Dr. Maurice Zeitlin
  
65
  
Director, Chairman - Nominating Committee; member, Compensation Committee and Audit Committee
Warren Breslow
  
64
  
Director, Chairman - Audit Committee; member, Nominating Committee and Compensation Committee
Salvador Diaz-Verson, Jr.
  
52
  
Director, Chairman, Compensation Committee; member, Audit Committee and Nominating Committee
         
Other Executive Officers
        
         
Yedidia Cohen
  
51
  
Vice President of Engineering
 
The following sets forth certain information with respect to our directors and executive officers.
 
Melvin Gagerman - Mr. Gagerman has been the CEO and CFO of the Company since we emerged from Chapter 11 proceedings on January 31, 2006. He has many years of experience in all aspects of managing companies and a very strong background in accounting and finance. Mr. Gagerman was the President of Hollywood Trading Co., a distributor of novelty items, from 2000 until February 2006, when he became CEO of the Company. Prior to that Mr. Gagerman was the CEO of Surface Protection Industries from 1976 to 1977, where he successfully reorganized key management positions; established relationships with new distributors and upgraded manufacturing abilities, developed aggressive marketing programs to revitalize mature product lines and identified new market opportunities to increase sales and profits. From 1973 to 1975 Mr. Gagerman was the Chairman and CEO of Applause, where he successfully reorganized a world famous designer, manufacturer and distributor of licensed and generic stuffed toys which had sales of $137 million per year, 700 employees and losses of 12 million dollars a year. By aggressively altering product lines, adding new lines, cutting overhead, restructuring several key management positions, the company produced a $4.5 million profit within one year. Mr. Gagerman has also served as Managing Partner of Good, Gagerman & Berns, an accounting firm, National Audit Partner for Laventhol and Horwath and Audit Supervisor at Coopers and Lybrand.
 
Arthur J. Schwartz, PhD - Dr. Schwartz has been CTO and a director of the Company since it emerged from Chapter 11 proceedings on January 31, 2006. From 2002 to 2006 Dr. Schwartz was a principal in the business consulting firm Aries Group Ltd. Dr. Schwartz is one of the founders of the Company and was a member of Aura’s management from1987 until 2002 as Executive Vice President, CTO and director. Dr. Schwartz has been has been involved in all technical aspects of the Company and has been instrumental in many of our government programs. Prior to founding Aura, Dr. Schwartz worked at Hughes Aircraft Company as a senior scientist on classified programs. Dr. Schwartz has a Ph.D in Physics.
 
Dr. Maurice Zeitlin - Dr. Maurice Zeitlin has been a director of the Company since it emerged from Chapter 11 proceedings on January 31, 2006. Since 1985, Dr Zeitlin has been the President and owner of Maurice A. Zeitlin M.D., a Medical Corporation. He currently practices administrative medicine and is the medical director for several Los Angeles area hospitals. Dr. Zeitlin was a Major in the USAF from 1972 until 1974 He attended the University of Chicago and received his M.D in 1967.
 
Warren Breslow - Mr. Breslow has been a director and Chairman of the Audit Committee since it emerged from Chapter 11 bankruptcy proceedings on January 31, 2006. Mr. Breslow is the General Partner and Chief Financial Officer of Goldrich & Kest Industries (“G & K Industries”), a property management firm. He joined G & K Industries in 1972 as controller and assumed his current position as General Partner and Chief Financial Officer in 1974. As General Partner and Chief Financial Officer of G & K, Mr. Breslow oversees the financial aspects of G & K’s construction activity, as well as their management operations and information systems center. He is also past president and lifetime member of the board of directors of the Stephen S. Wise Temple, and supports numerous charitable and civic organizations. Prior to his association with Goldrich & Kest Industries, Mr. Breslow was a manager with the International Accounting firm of Laventhol & Horwath. He is a CPA and graduated from the Bernard Baruch School of Business Administration.
 
28
 
Salvador Diaz-Verson, Jr. is a director of the Company and has served in this capacity since June, 2007. He previously served as a director of the Company from 1997 to 2005. Mr. Diaz-Verson is the founder, Chairman and President of Diaz-Verson Capital Investments, Inc., an Investment Adviser registered with the SEC, where he has served since 1991. Mr. Diaz-Verson served as President and member of the Board of Directors of American Family Corporation (AFLCAC Inc.) a publicly held insurance holding company, from 1979 until 1991. Mr. Diaz-Verson also served as Executive Vice President and Chief Investment Officer of American Family Life Assurance Company, subsidiary of AFLAC Inc., from 1976 through 1991. He is currently a Director of the board of Miramar Securities, Clemente Capital Inc., Regions Bank of Georgia and The Philippine Strategic Investment Holding Limited. Since 1992, Mr. Diaz-Verson has also been a member of the Board of Trustees of the Christopher Columbus Fellowship Foundation, appointed by President George H.W. Bush in 1992, and re-appointed by President Clinton in early 2000. Mr. Diaz-Verson is a graduate of Florida State University.

Yedidia Cohen - Mr. Cohen has been employed by us since July, 2001, developing numerous magnetic applications, and has been our VP of Engineering since May, 2006. Prior to being appointed VP of Engineering he was the lead engineer on the AuraGen mechanical tasks. Mr. Cohen has extensive experience in designing and building highly reliable and durable weapon systems. He spent much of his professional carrier at Raphael (Weapon development and testing facility for the Israeli Army). In addition to his vast experience in weapon systems, Mr. Cohen worked for Electric Power Corporation in Haifa, Israel, where he specialized in conceptual design of power generation plane, thermodynamic calculations, design of boilers, pressure vessels and heat exchangers. In addition to his engineering skills Mr. Cohen has experience in building and managing teams of engineers working on complex tasks. Mr. Cohen has a M.S.E.E degree in Mechanical Engineering from the Technion in Haifa, Israel
 
Section 16(a) Beneficial Ownership Reporting Compliance
 
Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), requires our officers and directors, and beneficial owners of more than ten percent of the common stock, to file with the Securities and Exchange Commission and the National Association of Securities Dealers, Inc. reports of ownership and changes in ownership of the common stock. Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to us during our fiscal year ended February 28, 2007, and Form 5 and amendments thereto furnished to us covering the 2007 fiscal year filed under Section 16(a) of the Securities Exchange Act of 1934, no person who was an officer or director or beneficial owner of more than 10% of our common stock failed to file on a timely basis, as disclosed in such Forms, the reports required by Section 16(a) of the Exchange Act during such fiscal year or prior fiscal years.
 
Code of Ethics

We have a Code of Ethics for all of our employees, including our Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer. The purpose of the Code is to ensure that our business is conducted in a consistently legal and ethical matter. A copy of our Code of Ethics is included as an exhibit to this Annual Report on Form 10-K.

Audit Committee

The Audit Committee of our Board of Directors recommends selection of independent public accountants to our Board, reviews the scope and results of the year-end audit with management and the independent auditors, reviews our accounting principles and our system of internal accounting controls and reviews our annual and quarterly reports before filing with the SEC. The current members of the Audit Committee are Warren Breslow, (Chairman), Dr. Maurice Zeitlin and Salvador Diaz-Verson. Our Board has determined that all members of the Audit Committee are “independent” under the rules of the SEC and the listing standards of NASDAQ. Our Board also determined that Mr. Breslow is an “audit committee financial expert” in accordance with applicable SEC regulations. The Audit Committee has adopted a written Audit Committee charter. A copy of our current Audit Committee Charter is included as an exhibit to this Annual Report on Form 10-K.

29
 
ITEM 11. EXECUTIVE COMPENSATION
 
COMPENSATION DISCUSSION AND ANALYSIS

Executive Compensation Policy and Objectives

Our policy in compensating executive officers, including the executive officers named in the Summary Compensation Table appearing below (the “named executive officers”), is to establish methods and levels of compensation that will

 
·
attract and retain highly qualified personnel
 
·
provide meaningful incentives to promote profitability and growth and reward superior performance.

To achieve these policies we follow the basic principles that annual compensation should be competitive with similar companies and long term compensation should generally be linked to the Company’s return to shareholders.
 
We also believe that compensation for individual executives should be aligned to the performance of areas of the business over which the executive has the most control.

Executive compensation policies are implemented through a combination of annual and long-term methods of compensation. Compensation for the named executive officers includes

 
·
base salary,
 
·
eligibility to receive annual cash bonuses, and
 
·
stock-based compensation in the form of stock options under employee stock option plans.
 
These primary components are available for flexible use by our company in a manner that will effectively implement our stated objectives with respect to compensation arrangements for each of the executive officers. Each of these components is discussed in more detail below. When setting the compensation arrangements for each executive officer, the Compensation Committee considers these components individually, as well as on an aggregate (total compensation) basis. There is no pre-determined relationship between base salary of our executives and any of the other principal components of compensation. Each element of compensation is considered both individually and in terms of total overall compensation.
 
Role of Company Management in Compensation Decisions
 
The Compensation Committee makes decisions regarding the compensation of the Chief Executive Officer usually in conjunction with input from the Chief Executive Officer, including base compensation, equity incentive awards, annual incentive award payments. The Chief Executive Officer annually reviews compensation for the other named executive officer and makes recommendations to the Compensation Committee based upon individual and company performance. The Compensation Committee reviews and approves, and may exercise discretion to modify, all recommendations made by the Chief Executive Officer.
 
Primary Components of Executive Compensation. 
 
Base Salary

The base salaries of our executive officers are set by the Compensation Committee after consideration of a number of factors, including the executive’s position, level of responsibility, tenure and performance. The Compensation Committee also considers the compensation levels of executives in comparable companies, along with the executive compensation recommendations made by our chief executive officer. In addition, the Compensation Committee evaluates whether the base salary levels of our executives are appropriate relative to our size and financial performance compared with the other companies reviewed. Relying primarily on these factors, the Compensation Committee sets the base salaries of our executive officers at levels designed to meet its objective of attracting and retaining highly qualified individuals. The Compensation Committee also believes that the continuity of leadership derived from the retention of well qualified executive officers is in the best interests of our shareholders. The base salaries of our executive officers are not set at any specific level as compared to the compensation levels of companies reviewed and the Compensation Committee does not assign relative weights or importance to any specific measure of the company’s financial performance.
 
30
 
Effective January 1, 2006, Mr. Gagerman’s base salary was set at $25,000 per month in connection with his appointment as Chairman of the Board and Chief Financial Officer. Mr. Gagerman’s base salary was later increased from $25,000 to $30,000 per month, effective November 1, 2006, pursuant to a written employment agreement (the “Gagerman Agreement”). The decision to increase Mr. Gagerman’s base salary was based primarily upon the increase in his responsibilities since May 2006, when he formally assumed the role of President and Chief Executive Officer.
 
Annual Cash Incentive Payment
 
We consider the use of annual performance bonuses from time to time where appropriate, to motivate participants to achieve company growth and enhance shareholder value. The incentive bonus plan permits plan participants to receive a cash bonus that is tied to the company’s performance and achievement of measures relating to an individual’s own performance during a specified fiscal year. The types of measures and relative weight of those measures used in determining annual incentive awards are tailored to the named executive officer’s position and responsibilities. We maintain an annual cash bonus plan for Mr. Gagerman, which was established effective November 1, 2006, beginning in fiscal year 2007, under the terms of the Gagerman Agreement. We do not presently have in effect an annual cash bonus plan in effect with respect to any other named executive officer.
 
The Gagerman Agreement provides for an annual bonus to be approved by the Board of Directors of up to $100,000 based on objective and subjective milestones and, in the case of the 2007 fiscal year, provided the company has the available cash, and an additional annual bonus at the discretion of the Board of Directors of up to $100,000 for achievements in excess of expected milestones. The initial qualitative milestones and their quantitative relative weight were specified in the Gagerman Agreement for fiscal 2007, fiscal 2008 and fiscal 2009, and relate to achievement of specified business, financial and organizational performance goals. The Compensation Committee may change both the qualitative goals and relative weight of the goals by giving notice to Mr. Gagerman prior to the fiscal quarter that the change will take effect. In addition, the Compensation Committee retains the discretion under the Gagerman Agreement to pay an annual bonus regardless of whether the stated milestones are achieved. The milestones are set with the expectation that it is probable that the milestones will be met in the applicable fiscal year. In December 2007 the Compensation Committee determined to award Mr. Gagerman a bonus of $100,000 for the fiscal 2007 year.
 
Long-Term Equity Based Compensation Awards
 
To date we have had limited cash flow from operations. As a result, we have placed special emphasis on equity-based compensation, in the form of options and warrants, to preserve our cash for operations. Long-term equity based compensation awards are granted to our executive officers pursuant to our equity plans. The Compensation Committee believes that long-term equity based compensation awards are an effective incentive for senior management to increase the long-term value of the company’s common stock as well as aiding the company in attracting and retaining senior management. These objectives are accomplished by making awards under the plan, thereby providing senior management with a proprietary interest in the continued growth and performance of the company and more closely aligning their interests with those of our shareholders. In addition, because options may sometimes terminate when an executive leaves the company, we believe that options are a useful incentive in promoting the retention of executives.
 
2006 Employee Stock Option Plan
 
 In September 2006 our Board of Directors adopted an employee stock option plan, which is subject to shareholder approval at our next annual meeting of shareholders. The option plan authorizes the Board of Directors or a committee of directors designated by the Board (the “Option Committee”) to grant up to 3,000,000 options to employees, directors and consultants. At the time of the option grant the Option Committee designates the option for federal tax purposes as an “incentive stock option” or “non-statutory stock option.” The named executive officers are eligible to receive option grants under the option plan. 
 
All determinations regarding the granting of options to executive officers, including the amount, exercise price, and terms of vesting, are made by the Option Committee after seeking input from management. The Option Committee makes long-term equity based compensation awards after a review of a number of factors, including length of service, the performance of the company, the relative levels of responsibility of the executive and his or her contributions to the business, including recommendations of supervisors, and prior option grants received by the executive. Awards may be granted to the same executive on more than one occasion.
 
31
 
 Stock option grants may be subject to a vesting period based upon continued employment during the option term or may fully vest upon grant. The Option Committee may make grants at any particular time during the year. The exercise price of the options must be at least equal to the fair market value of such shares on the date the stock option is granted or such later date as the Option Committee specifies.
 
In fiscal 2007, pursuant to the Gagerman Agreement, and following his appointment as CEO in May 2006, Mr. Gagerman was awarded a total of 300,000 options to purchase common stock under our employee stock option plan, exercisable at $2.00 per share, for a period of three years, of which 50,000 were designated as incentive stock options, the maximum amount allowable as incentive stock options under federal tax law for this grant. This grant primarily reflected his increased responsibilities as CEO. These 300,000 options were granted in addition to 600,000 warrants which were awarded to Mr. Gagerman in connection with his assuming the duties of Chairman and Chief Financial Officer effective February 2006. The 300,000 options vest at the rate of 25,000 per month. The Gagerman Agreement provides for acceleration of the vesting, and termination of the options prior to the expiration of the three year term, under circumstances specified in the Gagerman Agreement.
 
Subsequent to the end of fiscal 2007, in order to provide additional incentives to Mr. Gagerman, and in recognition of his accomplishments as both CEO and acting CFO, Mr. Gagerman was granted an additional 100,000 options, exercisable at $2.00 per share, with a term of five years. This grant is subject to shareholder approval. In addition, subsequent to the end of fiscal 2007, we determined to extend the term of his 600,000 warrants from three years to five years and to fix the exercise price at $2.00 per share during the term of the warrants, subject to shareholder approval.
 
Pursuant to our agreements with Mr. Gagerman, all of the options and warrants granted to him have a “cashless exercise feature” which allows Mr. Gagerman, at his option, to receive a reduced number of shares upon exercise of the options or warrants instead of paying the exercise price in cash.
 
Other Benefits. 
 
We provide all eligible employees, including executive officers, with certain benefits, including health and dental coverage, company-paid term life insurance coverage, disability insurance, 401(k) plan, paid time off and paid holiday programs. Other perquisites and personal benefits, such as automobile allowances and country club dues, are considered on a case-by-case basis. Executive Perquisites and benefits are provided to ensure overall compensation for named executive officers is adequate.

Our executive officers are eligible to participate in our 401(k) plan, with Mr. Cohen being the only executive officer to participate. We do not presently maintain any other deferred compensation or retirement plans.

We provide the foregoing benefit programs to provide executive officers with benefits that are competitive with those in the marketplace without incurring substantial cost to the company.

Employment Agreements. Other than our written employment agreement with Melvin Gagerman, we do not have employment agreements with any of our named executive officers and generally do not enter into long-term employment agreements with our executive officers. Information regarding Mr. Gagerman’s written employment agreement is discussed below.

Severance Agreements. Other than severance provisions contained in our written employment agreement with Melvin Gagerman, we generally do not enter into severance agreements or similar agreements providing for payments upon termination of employment or change-in-control. Such agreements, when entered into, are negotiated on a case-by-case basis.

Material Tax and Accounting Implications of Executive Compensation Program. 

SFAS 123R sets forth the accounting treatment for options effective March 1, 2006. This accounting rule requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Prior to March 1, 2006 we followed Accounting Principles Board Opinion No. 25 (“APB 25”), Accounting for Stock Issued to Employees, and related Interpretations for measurement and recognition of stock-based transactions with employees. Under APB 25, generally no compensation expense was recognized in connection with the grant of a stock option since at the date of grant, the exercise price of stock options was set either at, or above, current price at closing of market or, at the price at closing of market on a pre-determined future date. Because the adoption of SFAS 123R’s fair value method will have an impact on our results of operations, this may have an impact on the level of share-based payments being issued.
 
32
 
U.S. federal income tax law prohibits publicly held companies from deducting certain compensation paid to a named executive officer that exceeds $1 million during the tax year. To the extent that compensation is based upon the attainment of performance goals set by the Compensation Committee pursuant to plans approved by our shareholders, the compensation is not included in the computation of this limit. Although the Compensation Committee intends, to the extent feasible and where it believes it is in the best interests of the company and our shareholders, to attempt to qualify executive compensation as tax deductible, it does not intend to permit this tax provision to dictate the committee’s development and execution of effective compensation plans.

Tax Consequences of Incentive Stock Options. Our 2006 employee stock option plan authorizes the grant of both “incentive stock options” and “non-qualified stock options.” The grant of an incentive stock option will not result in any immediate tax consequences to us or the optionee. An optionee will not realize taxable income, and we will not be entitled to any deduction, upon the timely exercise of an incentive stock option, but the excess of the fair market value of the shares of our common stock acquired over the option exercise price will be includable in the optionee’s “alternative minimum taxable income” for purposes of the alternative minimum tax. If the optionee does not dispose of the shares of our common stock acquired within one year after their receipt, and within two years after the option was granted, gain or loss realized on the subsequent disposition of the shares of our common stock will be treated as long-term capital gain or loss.

Tax Consequences of Non-qualified Stock Options. In general, the grant of a non-qualified stock option or warrant will not result in any immediate tax consequences to us or the optionee. Upon the exercise of a non-qualified stock option or warrant, generally the optionee will realize ordinary income and we will be entitled to a deduction, in each case, in an amount equal to the excess of the fair market value of the shares of our common stock acquired at the time of exercise over the exercise price.
 
COMPENSATION COMMITTEE REPORT
 
The Compensation Committee has reviewed and discussed with management the “Compensation Discussion and Analysis” section included in this annual report. Based on this review and discussion, the Compensation Committee recommended to the board of directors that the “Compensation Discussion and Analysis” section be included in this annual report.

The Compensation Committee:

Warren Breslow
Dr. Maurice Zeitlin
Salvatore Diaz-Verson
 
33

The following table summarizes all compensation earned for the fiscal year ended February 28, 2007, to the individual who served as our chief executive officer during fiscal 2007, and the one other most highly compensated executive officer who was serving in such capacity as of February 28, 2007 (the "named executive officers").

2007 Summary Compensation Table
 
Name and Principal Position
 
Fiscal Year
  
Salary ($)
  
Option
Awards
($) [3]
  
Non-Equity Incentive Plan Compensation
  
All Other
Compensation ($)
  
Total
($)
  
                           
Melvin Gagerman (1)
   
2007
    
319,154
(2)
  
171,359
    
100,000(4
)
  
19,320
(5)
  
609,833
  
Chief Executive Officer,
Chief Financial Officer, and President
                                      
                                       
Yedidia Cohen
    
2007
    
164,285
                
808
(6)
  
165,093
  
Vice President of Engineering
                                      
 
(1)
Mr. Gagerman was elected Chairman and Chief Financial Officer effective February 1, 2006 and was elected President and Chief Executive Officer effective May 25, 2006.
(2)
Mr. Gagerman’s salary was $25,000 per month from January 1, 2006 until December 1, 2006 at which time it was increased to $30,000 per month.
(3)
Reflects the amount recognized for financial statement reporting purposes for fiscal 2007 in accordance with FAS 123R using the assumptions set forth in footnote 11 to the financial statements included elsewhere in this Annual Report for stock options and warrants granted during and prior to fiscal 2007, assuming no forfeitures.
(4)
Represents incentive plan cash bonus awarded to Mr. Gagerman for fiscal 2007, which has been earned but not yet paid.
(5)
Represents automobile and country club dues allowances, the cost of life insurance premiums, and medical expense reimbursements for fiscal 2007.
(6)
Represents Company matching contributions to the 401(k) plan.

No bonuses or stock awards were granted to the above individuals for the fiscal year ended February 28, 2007.

Grants of Plan-Based Awards in the Last Fiscal Year
 
The following table sets forth certain information at February 28, 2007, and for the year then ended, with respect to plan-based awards granted to the individuals named in the Summary Compensation Table above.

2007 GRANTS OF PLAN-BASED AWARDS TABLE
           
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards(3)(4)
  
Option Awards:
Number of
Securities
Underlying
Options
(#)
  
Exercise or
Base Price
of Option
Awards
($ / Sh)
  
Grant Date
Fair
Value of Option
Awards ($)(1)
Name  
Grant
Date (5)
  
Approval
Date (5)
  
Threshold
($)
  
Target
($)
  
Maximum
($)
            
(a)
  
(b)
  
(c)
  
(d)
  
(e)
  
(f)
            
Melvin Gagerman
  
11/01/06
  
12/01/06
              
300,000(2)
  
$2.00(2)
  
$56,359
   
n/a
  
n/a
  
(3)
  
$100,000
  
$200,000
  
-
  
-
  
-
                                 
Yedidia Cohen
      
-
  
-
  
-
  
-
  
-
  
-
  
-

 
(1)
Reflects the full grant date fair market value, computed in accordance with FAS 123R using the assumptions set forth in footnote 11 to the financial statements included elsewhere in this Annual Report for stock options and warrants granted in fiscal 2007, assuming no forfeitures. 
 
(2)
Options vest at the rate of 25,000 per month from the date of grant and are exercisable at a price of $2.00 per share, with an initial term of three years. Subsequent to the end of fiscal 2007 the term of these options were extended from three years to five years. Under the terms of our Bylaws, this grant is subject to shareholder approval.
 
(3)
The written employment agreement with Mr. Gagerman (the Gagerman Agreement) provides for an annual bonus in each fiscal year to be approved by the Board of Directors of up to $100,000 based on objective and subjective milestones and, in the case of the 2007 fiscal year, provided the company has the available cash, and an additional annual bonus at the discretion of the Board of Directors of up to $100,000 for achievements in excess of expected milestones. The initial qualitative milestones and their quantitative relative weight were specified in the Gagerman Agreement for fiscal 2007, fiscal 2008 and fiscal 2009, and relate to achievement of specified business, financial and organizational performance goals. The Compensation Committee may change both the qualitative goals and relative weight of the goals by giving notice to Mr. Gagerman prior to the fiscal quarter that the change will take effect. In addition, the Compensation Committee retains the discretion under the Gagerman Agreement to pay an annual bonus regardless of whether the stated milestones are achieved. In December 2007 the Compensation Committee determined to award Mr. Gagerman a bonus of $100,000 for the fiscal 2007 year, which amount is reflected in the Summary Compensation Table. He remains eligible for bonuses in future fiscal years.
 
(4)
Column (e) represents the amount payable if all of the annual targets are met, and column (f) represents the maximum amount payable under the plan established in the Gagerman Agreement.
 
(5)
The grant date reflects the effective date of the equity grant for financial statement purposes under FAS 123R, which corresponds to the stated effective date of the Gagerman Agreement containing the grant. The approval date reflects the date the Compensation Committee formally approved the Gagerman Agreement.

34

Outstanding Equity Awards at 2007 Fiscal Year-End

The following table summarizes certain information regarding the number and value of all options to purchase our common held by the individuals named in the Summary Compensation Table at February 28, 2007. No stock awards or equity incentive plan awards were issued or outstanding during fiscal 2007.

2007 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END

   
Option Awards 
   
Number ofSecurities Underlying Unexercised Options
(#)
  
Number of
Securities
Underlying
Unexercised
Options
(#)
  
Equity
Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
    
Option
Exercise
Price
    
Option
Expiration
Name  
Exercisable 
  
Unexercisable
  
(#)
  
($) 
  
Date 
                     
Melvin Gagerman (a)(b)
  
250,000(b)
  
0(b)
  
--
  
$2.50(a)
  
1/31/09
Melvin Gagerman (c)(d)
  
350,000(d)
  
0(d)
      
$2.50(c)
  
1/31/09
Melvin Gagerman (e)
  
75,000(e)
  
225,000(e)
      
$2.00     
 
11/1/09
Yedidia Cohen
  
--
  
--
  
--
        

 
(a)
Effective January 31, 2006, Mr. Gagerman was awarded 250,000 Management Warrants by our Board of Directors as authorized under our Chapter 11 Plan of Reorganization. The terms of the Management Warrants provide for an exercise price of $2.00 per share during the first twelve (12) months from the effective date of issuance (January 31, 2006), $2.50 per share from the 13th to the 24th months from the effective date of issuance; and $3.00 per share from the 25th to the 36th month from the effective date of issuance. However, under the terms of Mr. Gagerman’s employment agreement, which are subject to shareholder approval under our Bylaws, the exercise price will be $2.00 per share. The exercise price in the table does not reflect shareholder approval. Subsequent to the end of fiscal 2007 the term of these options was extended from three years to five years, subject to shareholder approval.
 
 
(b)
The Management Warrants vest over a 36 month period: 1/36th of the shares of common stock underlying the warrant vest each month after the date of issuance, subject to his continuing to serve as an employee. However, under the terms of Mr. Gagerman’s employment agreement, which are subject to shareholder approval under our Bylaws, the warrants were fully vested as of May 1, 2006. The vesting information in the table assumes shareholder approval.
 
 
(c)
Effective January 31, 2006, Mr. Gagerman was awarded 350,000 Director Warrants by our Board of Directors as authorized under our Chapter 11 Plan of Reorganization. The terms of the Director Warrants provide for an exercise price of $2.50 per share. However, under the terms of Mr. Gagerman’s employment agreement, which are subject to shareholder approval under our Bylaws, the exercise price will be $2.00 per share. The exercise price in the table does not reflect shareholder approval. Subsequent to the end of fiscal 2007 the term of these options was extended from three years to five years, subject to shareholder approval.
 
35
 
 
(d)
The Director Warrants vest over a two year period: 25% of the shares of common stock underlying the warrant vest each six months after the effective date of issuance (January 31, 2006). However, under the terms of Mr. Gagerman’s employment agreement, which are subject to shareholder approval under our Bylaws, the warrants were fully vested as of May 1, 2006. The vesting information in the table assumes shareholder approval.
 
 
(e)
These options were granted pursuant to the Gagerman Agreement entered into effective November 1, 2006. Options vest at the rate of 25,000 per month from the date of grant (November 1, 2006) and are exercisable at a price of $2.00 per share, with a term of three years. Subsequent to the end of fiscal 2007 the term of these options was extended from three years to five years. Under the terms of our Bylaws, this grant is subject to shareholder approval.

Option Exercises and Stock Vesting During 2007

No stock options were exercised during fiscal 2007 by the individuals named in the Summary Compensation Table. No stock awards were issued or outstanding during fiscal 2007.
 
Employment Contracts, Termination of Employment Contracts and Change in Control Arrangements
 
Gagerman Employment Agreement

Effective November 1, 2006, we entered into a written employment agreement with Melvin Gagerman (the “Gagerman Agreement”) regarding the terms and conditions of his employment as CEO. The Gagerman Agreement originally was in effect through February 28, 2010, and is automatically extended by an additional year at the beginning of each fiscal year unless we give prior notice of our intent not to extend the agreement. Accordingly, the Gagerman Agreement is currently in effect until February 28, 2011. The agreement may be terminated before its stated expiration by either of the parties under specified terms and conditions Following are the material terms of the Gagerman Agreement.

Base Salary and Annual Bonus. 

Mr. Gagerman is entitled to a base salary of $360,000 per year. The Gagerman Agreement also provides for an annual bonus to be approved by the Board of Directors of up to $100,000 based on objective and subjective milestones and, in the case of the 2007 fiscal year, provided the company has the available cash, and an additional annual bonus at the discretion of the Board of Directors of up to $100,000 for achievements in excess of expected milestones. The initial qualitative milestones and their quantitative relative weight were specified in the Gagerman Agreement for fiscal 2007, fiscal 2008 and fiscal 2009, and relate to achievement of specified business, financial and organizational performance goals. The company may change both the qualitative goals and relative weight of the goals by giving notice to Mr. Gagerman prior to the fiscal quarter that the change will take effect. In addition, we retain the discretion under the Gagerman Agreement to pay an annual bonus regardless of whether the stated milestones are achieved. Bonuses are payable within 45 days after the end of the applicable fiscal year.
 
Stock Options

The Gagerman Agreement provides for him to receive options to purchase 300,000 shares of Common Stock at an exercise price of $2.00 per share, of which 50,000 options are designated for tax purposes as “incentive stock options” and the remaining options are non-qualified options. The Gagerman Agreement originally provided for a term of three years, but was subsequently extended to five years. The options vest at the rate of 25,000 per month. Unvested options vest if the Gagerman Agreement is terminated by either party under specified circumstances. All of these options vested as of November 2007.

Life Insurance, Dues and Car Allowance

The Gagerman Agreement requires us to pay life insurance premiums on his private life insurance policy, up to $7,500 per year. Mr. Gagerman is also entitled to receive $2,000 per month as an automobile allowance and country club dues, and reimbursement of the country club initiation fee of up to $8,000.
 
36
 
Medical Benefits
 
In addition to health and dental insurance generally available to all of our employees, Me. Gagerman is also entitled to receive reimbursement of up to $15,000 per year for all non-covered medical and dental expenses for himself and his spouse, including deductibles and co-payments. His agreement also entitles him to reimbursement for the cost of long term care insurance.

Early Termination of Agreement

The Gagerman Agreement provides that either party may terminate the agreement prior to its stated term of February 28, 2010, upon occurrence of the following events:

 
·
Death or Permanent Disability - The agreement automatically terminates upon Mr. Gagerman’s death or disability (as determined under our Long-Term Disability Plan, which provides for a benefit of 50% of his monthly salary to a maximum of $6,000 per month).

 
·
By the Company For Cause - We may terminate the agreement for “cause”. The agreement defines “cause” to include:

 
·
a breach by Mr. Gagerman of his obligations not to compete with us during the term of his employment;
 
·
a breach by Mr. Gagerman of his obligation to maintain confidential information
 
·
commission of an act of fraud, embezzlement or dishonesty which is injurious to us;
 
·
intentional misconduct which is detrimental to our business or reputation

 
·
By the Company for Non-Performance - We may terminate the agreement upon 120 days prior notice in the event of “non-performance” by Mr. Gagerman. The agreement defines “non-performance” to mean a determination by not less than 75% of the members of our Board of Directors that Mr. Gagerman is not performing his duties as CEO and the continuation of the non-performance for 15 days after receiving notice of the Board’s determination.

 
·
By The Company Without Cause or Non-Performance - We may terminate the agreement upon not less than 12 months notice, without regard to Mr. Gagerman’s performance.

 
·
By Mr. Gagerman For Cause - Mr. Gagerman may terminate the agreement for “cause” upon not less than 45 days notice. The agreement defines “cause” to include:

·
A change in his job responsibilities resulting from a demotion; and
·
His removal as a member of the Board of Directors.

 
·
By Mr. Gagerman Without Cause - Mr. Gagerman may terminate the agreement upon not less than 120 days notice without regard to whether we are meeting our obligation under the agreement.

 
·
By Mr. Gagerman Upon a Change of Control - Mr. Gagerman may terminate the agreement upon not less than 30 days notice at any time following a “change in control.” The agreement defines change of control to mean:

 
·
The acquisition by a new investor of more than 50% of our common stock, or
 
·
The change of a majority of our board members either by an individual or by one or more groups acting together. 
 
Severance Benefits Upon Termination

Base Salary and Bonus. Upon the termination of Mr. Gagerman’s employment as CEO, he is entitled to receive accrued salary, unpaid bonus payments (if any) through the effective date of his termination.

Employee Benefits. All employee benefits, including life insurance premiums and automobile and dues allowances, cease to accrue as of the date of termination.
 
37
 
Stock Options - Upon the termination of Mr. Gagerman’s employment as CEO the portion of the 300,000 options which are vested as of the date of termination remain exercisable in accordance with their terms. The unvested portion of the 300,000 options terminate upon termination of the agreement unless:

 
·
termination is a result of a “change in control” or
 
·
We terminate the agreement other than for “cause” or “non-performance.”

in which case the unvested options become fully exercisable upon termination. 

Lump Sum Severance Payment - Under the terms of the agreement Mr. Gagerman is entitle to a lump sum severance payment within 45 days of termination equal to the greater of one year’s base salary ($360,000), or the unpaid balance of the base salary which would have been payable if Mr. Gagerman remained employed through the stated term of employment in effect immediately prior to the termination if:

 
·
termination is a result of a “change in control”
 
·
Mr. Gagerman terminates the agreement for “cause” or
 
·
We terminate the agreement other than for “cause” or “non-performance.”

Each of these events is referred to as a “severance payment event.”

Potential Payments to the Named Executive Officers Upon Termination or Change in Control

Other than the benefits provided for in Mr. Gagerman’s written employment agreement, which are described above, none of the named executive officers are entitled to any payments or benefits upon termination, whether by change in control or otherwise, other than benefits available generally to all employees.

Upon the occurrence of a severance payment event for Mr. Gagerman, assuming he were terminated as of February 28, 2007, he would be entitled to a severance payment of $1,080,000, payable within 45 days of the date of his termination.

Mr. Gagerman was the only named executive officer with unvested options or warrants outstanding as of February 28, 2007. The vesting of unvested options is accelerated upon termination of Mr. Gagerman’s employment under the circumstances described above. However, none of Mr. Gagerman’s were exercisable at a price less than the closing price of our Common Stock as of February 28, 2007.
 
Director Compensation During Fiscal 2007

The following table summarizes all compensation paid to directors other than named executive officers during fiscal 2007.

2007 DIRECTOR COMPENSATION TABLE

Name
  
Fees
Earned
or Paid
in Cash
($)
  
Stock
Awards
($)
  
Option
Awards
($) (1)(2)
  
Non-Equity
Incentive Plan
Compensation
($)
  
All Other
Compensation
($)
  
Total
($)
Arthur J. Schwartz (4)
  
-
  
-
  
6,617
  
-
  
142,231(10)
  
148,848
Maurice Zeitlin (5)
  
-
  
-
  
6,617
  
-
  
-
  
6,617
Warren Breslow (6)
  
-
  
-
  
6,617
  
-
 
-
  
6,617
Sheldon Appel (3)(7)
  
-
  
-
   
6,617
  
-
 
-
  
6,617
Salvador Diaz-Verson, Jr. (8)(9)
  
-
  
-
  
-
  
-
  
-
  
-
 
 
(1)
Reflects the amount recognized for financial statement reporting purposes for fiscal year 2007 in accordance with FAS 123(R) using the assumptions set forth in the footnote 11 to the financial statements included elsewhere in this Annual Report for stock option awards granted during and prior to 2007, assuming no forfeitures.
 
(2)
In fiscal 2007 Messrs. Zeitlin and Breslow were each granted Director Warrants (options) to acquire 25,000 shares, of our common stock at an exercise price of $2.50 per share, respectively, being the fair market value of our common stock on the date of grant, which options vest at a rate of 25% every six months and expire in May, 2009. The fair market value of each of these options at the time of grant, computed in accordance with FAS 123(R), was $13,233.
 
38
 
 
(3)
Mr. Appel resigned as a director in June, 2007.
 
(4)
The director had 25,000 options outstanding as of February 28, 2007.
 
(5)
The director had 25,000 options outstanding as of February 28, 2007.
 
(6)
The director had 25,000 options outstanding as of February 28, 2007.
 
(7)
The director had 12,500 options outstanding as of February 28, 2007.
 
(8)
The director had 0 options outstanding as of February 28, 2007.
 
(9)
Mr. Diaz-Verson, Jr. was appointed as a director on January 19, 2007.
 
(10)
Dr. Schwartz was a consultant to the company from March 1, 2006, until November 30, 2006, at which time he became an employee of the company.
 
Our Board of Directors may, at its discretion, compensate directors for attending board and committee meetings and reimburse the directors for out-of-pocket expenses incurred in connection with attending such meetings. Our directors are also eligible to receive stock option grants under our 2006 employee stock option plan and Director Warrants authorized under our Chapter 11 Plan of Reorganization.
 
Compensation Committee Interlocks and Insider Participation
 
During the 2007 fiscal year our Compensation Committee was comprised of Messrs. Breslow, Appel and Zeitlin. None of the members of the Compensation Committee was an executive officer or employee of the Company. During the 2007 fiscal year, none of our executive officers served on our Compensation Committee.
 
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 
Common Stock
 
The following table sets forth, to the extent of our knowledge, certain information regarding our common stock owned as of December 31, 2007 (i) by each person who is known to be the beneficial owner of more than five percent (5%) of our outstanding Common Stock, (ii) by each of our Directors and the named executive officers in the Summary Compensation Table, and (iii) by all Directors and current executive officers as a group:
 
 
Beneficial Owner
  
 
Number of Shares of Common Stock
  
Percent of Common Stock (1)
  
           
ICM Asset Management, Inc. (2)(3)
    
1,492,388
    
4.1
%
James M. Simmons (2)(4)
    
1,612,012
   
4.4
%
Koyah Ventures, LLC (2)(5)
    
1,541,238
    
4.2
%
Koyah Leverage Partners, L.P. (2)(6)
    
1,260,978
    
3.4
%
Melvin Gagerman (7)
    
611,501
    
1.7
%
Arthur Schwartz (8)
    
728,659
    
2.0
%
Maurice Zeitlin (9)
    
1,116,260
    
3.0
%
Warren Breslow (10)
    
1,488,378
    
4.1
%
Salvador Diaz-Verson, Jr. (11)
    
115,934
    
*
  
Yedidia Cohen (12)
    
57,962
    
*
  
               
All current executive officers and Directors as a group (six)
   
4,118,694
    
11.2
%
 
* Less than 1% of outstanding shares.
 
39
 
(1)
Beneficial ownership is determined in accordance with rules of the U.S. Securities and Exchange Commission. The calculation of the percentage of beneficial ownership is based upon 36,670,820 shares of common stock outstanding on December 31, 2007. In computing the number of shares beneficially owned by any shareholder and the percentage ownership of such shareholder, shares of common stock which may be acquired by a such shareholder upon exercise or conversion of warrants or options which are currently exercisable or exercisable within 60 days of December 31, 2007, are deemed to be exercised and outstanding. Such shares, however, are not deemed outstanding for purposes of computing the beneficial ownership percentage of any other person. Shares issuable upon exercise of warrants and options which are subject to shareholder approval are not deemed outstanding for purposes of determining beneficial ownership. Except as indicated by footnote, to our knowledge, the persons named in the table above have the sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.
(2)
Based upon information contained in Schedule 13G jointly filed with the SEC on February 13, 2008, by ICM Asset Management, Inc., Koyah Ventures, LLC, Koyah Leverage Partners, L.P. and James M. Simmons. The business address of these filers is 601 W. Main Avenue, Suite 600, Spokane, Washington 99201. ICM Asset Management, Inc., James M. Simmons and Koyah Ventures, LLC constitute a group sharing beneficial ownership within the meaning of Rule 13d-5(b)(1), but are not part of a group with any other person. Koyah Leverage Partners, L.P. expressly disclaims membership in a group and disclaims beneficial ownership of the common stock covered by the Schedule 13G. ICM Asset Management, Inc. is a registered investment adviser whose clients have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock. James M. Simmons is the Chief Executive Officer and controlling shareholder of ICM Asset Management, Inc. and the manager and controlling owner of Koyah Ventures, LLC. Koyah Ventures, LLC is the general partner of Koyah Leverage Partners, L.P. and other investment limited partnerships of which ICM Asset Management, Inc. is the investment adviser. No individual client of ICM, other than Koyah Leverage Partners, L.P., holds more than five percent of the outstanding common stock.
(3)
Includes sole dispositive and voting power of 862 shares and shared voting and dispositive power of 1,491,526 shares.
(4)
Includes sole dispositive and voting power of 7,771 shares and shared voting and dispositive power of 1,612,012 shares.
(5)
Includes sole dispositive and voting power of 119,503 shares and shared voting and dispositive power of 1,421,735 shares.
(6)
Includes shared dispositive and voting power of 1,260,678 shares.
(7)
Includes 446,639 warrants and options exercisable within 60 days of December 31, 2007.
(8)
Includes 157,433 warrants and options exercisable within 60 days of December 31, 2007.
(9)
Includes 157,757 warrants and options exercisable within 60 days of December 31, 2007.
(10)
Includes 279,313 warrants and options exercisable within 60 days of December 31, 2007.  
(11)
Includes 60,989 warrants and options exercisable within 60 days of December 31, 2007.
(12)
Includes 51,327 warrants and options exercisable within 60 days of December 31, 2007.
 
 
The mailing address for the officers and directors is c/o Aura Systems, Inc., 2330 Utah Avenue, El Segundo, CA 90245.
 
40

Securities Authorized for Issuance Under Equity Compensation Plans as of February 28, 2007

Equity Compensation Plan Information as of February 28, 2007

 
 
 
 
 
 
 
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
 
 
 
Weighted-average Exercise Price of Outstanding Options, Warrants and Rights
 
 
 
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
Plan Category
 
(a)
 
(b)
 
(c)
 
 
 
 
 
 
 
Equity compensation plans approved by security holders
 
802,778
 
$2.15
 
197,222
 
 
 
 
 
 
 
Equity compensation plans not approved by security holders
 
 
 
 
 
3,000,000
 
 
 
 
 
 
 
Total
 
802,778
 
$2.15
 
3,197,222
 
We maintain three equity compensation plans as of February 28, 2007, two of which have been approved by our security holders, and one which has not yet been submitted to security holders. Under our Chapter 11 Bankruptcy Plan of Reorganization, which was approved by our creditors and shareholders and became effective in January 2006, a total of 500,000 warrants to purchase our common stock were reserved for issuance to management from time to time and 500,000 warrants were reserved for issuance to our directors from time to time.
 
2006 Employee Stock Option Plan - In September 2006 our Board of Directors adopted the 2006 Employee Stock Option Plan (the “Option Plan”). The Option Plan authorizes the Board of Directors or a committee of directors designated by the Board to grant up to 3,000,000 options to employees, directors and consultants. The Option Plan and the options granted under the Option Plan are subject to shareholder approval at the next Annual Meeting of Shareholders. For further information regarding the terms of the Option Plan see “Item 11 - Compensation Discussion and Analysis - Long-Term Equity Based Compensation Awards.”
 
 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
 
Related Transactions
 
Since the beginning of the 2007 fiscal year, Mr. Breslow, a director, has made various temporary advances to the Company totaling $900,000. The highest amount outstanding at any one time was $500,000, and as of January 31, 2008, there is an outstanding balance of $500,000. Mr. Breslow also participated in a private placement with the Company in the amount of $850,000. Interest on the advances was at a rate of 10% per annum and totaled $1,452.05 through January 31, 2008.
 
Mr. Schwartz, a director, has made various temporary advances to the Company totaling $175,000. The highest amount outstanding at any one time was $100,000, and as of January 31, 2008, there was no outstanding balance. Mr. Schwartz also participated in a private placement with the Company in the amount of $13,000. Interest on the advances was at a rate of 10% per annum and totaled $794.52 through January 31, 2008.
 
41
 
Review and Approval of Related Party Transactions
 
Our Audit Committee is responsible for the review and approval of all related party transactions required to be disclosed to the public under SEC rules. This procedure, which is contained in the written charter of our Audit Committee, has been established by our Board of Directors in order to serve the interests of our shareholders. Related party transactions are reviewed and approved by the Audit Committee on a case-by-case basis. Under existing, unwritten policy no related party transaction can be approved by the Audit Committee unless it is first determined that the terms of such transaction is on terms no less favorable to us than could be obtained from an unaffiliated third party on an arms-length basis and is otherwise in our best interest.
 
Director Independence  
 
Our Board is comprised of a majority of independent directors under the rules of the SEC and the listing standards of NASDAQ. Our independent directors are Messrs. Zeitlin, Breslow, and Diaz-Verson. Richard Armbrust, a director in fiscal 2007 until resigning in May, 2006, was an independent director and was a member of the Audit Committee, Nominating Committee and Compensation Committee. Sheldon Appel served as a director in fiscal 2007 and resigned in June, 2007. Mr. Appel was an independent director and served on the Audit Committee, Nominating Committee and Compensation Committee Our Board has determined that each member of the Audit Committee, Compensation Committee and Nominating Committee is independent under such rules and standards. Messrs. Gagerman and Schwartz are not independent directors under applicable SEC rules.
 
ITEM 14. PRINCIPAL ACCOUNTING FEES AND DISCLOSURES
 
The Audit Committee regularly reviews and determines whether specific non-audit projects or expenditures with our independent auditors potentially affect their independence. The Audit Committee’s policy is to pre-approve all audit and permissible non-audit services provided by our independent auditors. Pre-approval is generally provided by the Audit Committee for up to one year, as detailed as to the particular service or category of services to be rendered, as is generally subject to a specific budget. The Audit Committee may also pre-approve additional services of specific engagements on a case-by-case basis.
 
The following table sets forth the aggregate fees billed to us by Kabani & Co. for the year ended February 28, 2007 and 2006: 

 
  
Year Ended February 28,
  
 
  
2007
  
2006
  
Audit Fees(1)
  
$
82,500
   $ 82,500  
Audit-related fees(2)
    
-
     -  
Tax fees(3)
    
-
     -  
All other fees(4)
    
-
     -  
 
            
Total
  
$
82,500
   $ 82,500  
 
     
(1)
 
Included fees for professional services rendered for the audit of our annual financial statements and review of our annual report on Form 10-K and for reviews of the financial statements included in our quarterly reports on Form 10-Q for the first three quarters of the years ended February 28, 2007 and 2006.
 
    
(2)
 
Includes fees for professional services rendered in connection with our evaluation of internal controls.
 
42
 
Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors

The Audit Committee pre-approves all audit and permissible non-audit services provided by our independent auditors. These services may include audit services, audit-related services, tax and other services. Pre-approval is generally provided for up to one year, and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific budget. The independent auditors and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent auditors in accordance with this pre-approval, and the fees for the services performed to date. The Audit Committee may also pre-approve particular services on a case-by-case basis. During fiscal 2006 and 2007 all services provided by Kabani and Company were pre-approved by the Audit Committee in accordance with this policy.
 
PART IV
 
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
 
Documents filed as part of this Form 10-K:
 
1.      Financial Statements
 
See Index to Consolidated Financial Statements at page F-1
 
2.      Financial Statement Schedules
 
See Index to Consolidated Financial Statements at page F-1
 
3.      Exhibits
 
See Exhibit Index
 
43
 
INDEX TO EXHIBITS
 
Description of Documents
 
2.1
First Amended Plan of Reorganization of Aura Systems, Inc.(2)
3.1
Amended and Restated Certificate of Incorporation of Aura Systems, Inc.. (1)
3.2
Amended and Restated Bylaws of Aura Systems, Inc. as amended to date. (1)
10.1
Form of Unsecured Creditor Warrants issued under First Amended Plan of Reorganization of the Company. (3)
10.2
Form of Management Warrants issued under First Amended Plan of Reorganization of Aura Systems, Inc.(3)
10.3
Form of Director Warrants issued under First Amended Plan of Reorganization of t Aura Systems, Inc. (3)
10.4
Aura Systems, Inc. 2006 Stock Option Plan. (3)
10.5
Form of Aura Systems, Inc. Non-Statutory Stock Option Agreement. (3)
10.6
Employment Agreement dated January 4, 2007, by and between the Company and Melvin Gagerman. (3)
10.7
Full Release dated as of January 31, 2006, by Aura Systems, Inc. for the benefit of Koyah Leverage Partners, L.P., Koyah Partners, L.P. Koyah Ventures LLC, Raven Partners, L.P., Koyah Microcap Partners Master Fund, L.P. and James M. Simmons. (3)
10.8
Consolidated, Amended and Restated Security Agreement dated as of January 31, 2006, by Aura Systems, Inc. for the benefit of Koyah Leverage Partners, L.P., Koyah Partners, L.P. Koyah Ventures LLC, Raven Partners, L.P., and Koyah Microcap Partners Master Fund, L.P. (3)
10.9
Consolidated, Amended and Restated Stock Pledge Agreement dated as of January 31, 2006, by Aura Systems, Inc. for the benefit of Koyah Leverage Partners, L.P., Koyah Partners, L.P. Koyah Ventures LLC, Raven Partners, L.P., and Koyah Microcap Partners Master Fund, L.P. (3)
10.10
Amended and Restated Intercreditor Agreement dated as of January 31, 2006, by and among Aura Systems, Inc., Koyah Leverage Partners, L.P., Koyah Partners, L.P. Koyah Ventures LLC, Raven Partners, L.P., and Koyah Microcap Partners Master Fund, L.P. (3)
10.11
Amended and Restated Promissory Note dated January 31, 2006, by Aura Systems, Inc. in favor of Raven Partners, L.P. (3)
10.12
Amended and Restated Promissory Note dated January 31, 2006, by Aura Systems, Inc. in favor of Koyah Ventures, LLC (3)
10.13
Consolidated, Amended and Restated Promissory Note dated January 31, 2006, by Aura Systems, Inc. in favor of Koyah Partners, L.P. (3)
10.14
Consolidated, Amended and Restated Promissory Note dated January 31, 2006, by Aura Systems, Inc. in favor of Koyah Microcap Partners Master Fund, L.P. (3)
10.15
Consolidated, Amended and Restated Promissory Note dated January 31, 2006, by Aura Systems, Inc. in favor of Koyah Leverage Partners, L.P. (3)
10.16
Lease between Aura Systems Inc., and Alliance Commercial Partners (3)
10.17
Lease between Aura Systems Inc., and Derek Lidow as Trustee for the Lidow Family Trust and Alexander Lidow (3)
14.1
Code of Ethics (3)
31.1
CEO Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
31.2
CFO Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.1
Certification pursuant to 18 U.S.C. Section 1350
 
(1)
Incorporated by reference from the Company's Report on Amendment to Form 8-A filed with the SEC on January 31, 2006.
(2)
Incorporated by reference from the Company’s Current Report on Form 8-K filed with the SEC on January 20, 2006.
(3)
Incorporated by reference from the Company’s Report on Form 10-K filed with the SEC for the year ended February 28, 2005.
 
44
 
Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
     
  AURA SYSTEMS, INC.
 
 		  
 		  
 
Dated: March __, 2008 By:   /s/ Melvin Gagerman
 
Melvin Gagerman
Chief Executive Officer
   
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.
 

Signatures
  
Title
   Date
         
/s/ Melvin Gagerman
  
Chief Executive Officer, Acting Chief Financial Officer Director and
  March __ , 2008
Melvin Gagerman
   Chairman of the Board (Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer)    
 
 
 
   
/s/ Arthur Schwartz
  
Director
    March __ , 2008
Arthur Schwartz
        
 
 
 
   
/s/ Maurice Zeitlin
   Director    March __ , 2008
Maurice Zeitlin
  
 
   
 
  
 
    
/s/ Warren Breslow
   Director    March __ , 2008
Warren Breslow
  
 
   
 
  
 
  
/s/ Salvador Diaz-Verson, Jr.
   Director    March __ , 2008
Salvador Diaz-Verson, Jr.
  
 
   
 
45
 
Index to Consolidated Financial Statements
 
Independent Auditors' Reports on Consolidated Financial Statements and Financial Statement Schedule
    
F-2
  
 
     
Consolidated Financial Statements of Aura Systems, Inc. and Subsidiaries:
      
 
     
Consolidated Balance Sheets - February 28, 2007 and February 28, 2006
    
F-3
  
Consolidated Statements of Operations - Years ended February 28, 2007, February 28, 2006 and February 28, 2005
    
F-4
  
Consolidated Statements of Stockholders' Equity (Deficit) - Years ended February 28, 2007, February 28, 2006 and February 28, 2005
    
F-5
  
Consolidated Statements of Cash Flows - Years ended February 28, 2007, February 28, 2006 and February 28, 2005
    
F-6 to F-8
  
Notes to Consolidated Financial Statements
    
F-8 to F-21
  
Consolidated Financial Statement Schedule II: Valuation and Qualifying Accounts
    
F-23
  
 
Schedules other than those listed above are omitted because they are not required or are not applicable, or the required information is shown in the respective consolidated financial statements or notes thereto.
 
F-1
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Board of Directors and Stockholders
 
Aura Systems, Inc. and subsidiaries
 
We have audited the accompanying consolidated balance sheets of Aura Systems, Inc. (a Delaware corporation) and subsidiaries as of February 28, 2007 and February 28, 2006, and the related consolidated statements of operations, stockholders' equity (deficit), and cash flows for each of the three years in the period ended February 28, 2007. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
 
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Aura Systems, Inc. and subsidiaries as of February 28, 2007 and February 28, 2006, and the results of their operations and their cash flows for each of the three years in the period ended February 28, 2007 in conformity with accounting principles generally accepted in the United States of America.
 
/s/ Kabani & Company, Inc.
Certified Public Accountants

Los Angeles, California
September 12, 2007

F-2
 
 
CONSOLIDATED BALANCE SHEETS
 
 
 
February 28, 2007
  
February 28, 2006
  
ASSETS
  
 
 
 
 
Current assets
  
 
 
 
 
Cash and cash equivalents
  
$
1,051,259
  
$
472,482
  
Accounts receivable, net of allowance for doubtful accounts of $164,241 and $164,241
    
249,984
    
87,808
  
Current inventories
   
750,000
    
615,000
  
Other receivables
    
-
    
2,654,864
  
Other current assets
    
243,854
    
69,690
  
Total current assets
    
2,295,097
    
3,899,844
  
 
             
Property, plant, and equipment, net
    
58,517
    
26,669
  
Non-current inventories net of allowance for obsolete inventories of $3,268,374 and $2,967,751
    
3,195,523
    
3,964,864
  
 
              
Total assets
  
$
5,549,137
  
$
7,891,377
  
 
              
LIABILITIES AND STOCKHOLDERS' EQUITY
      
Current liabilities
              
Accounts payable
  
$
216,225
  
$
590,577
  
Current portion of notes payable
   
611,411
    
48,766
  
Accrued expenses
   
470,092
    
528,192
  
Deferred income
   
164,625
    
164,625
  
 
              
Total current liabilities
    
1,462,353
    
1,332,160
  
 
             
Notes payable, net of current portion
    
1,983,118
    
2,476,234
  
 
              
Total liabilities
    
3,445,471
    
3,808,394
  
 
             
Commitments and contingencies
            
 
           
Stockholders' equity
           
Common stock, $0.0001par value, 50,000,000 shares authorized, 28,695,638 and 24,282,710 issued and outstanding at February 28, 2007 and 2006
    
2,870
    
2,428
  
Additional paid-in capital
    
347,261,713
    
343,073,025
  
Accumulated deficit
    
(345,160,917
)
  
(338,992,470
)
 
              
Total stockholders' equity
   
2,103,666
    
4,082,983
  
 
              
Total liabilities and stockholders' equity
 
$
5,549,137
  
$
7,891,377
  

The accompanying notes are an integral part of these financial statements

F-3
 
 
CONSOLIDATED STATEMENTS OF OPERATIONS
 
For the Years Ended February 28, 2007, February 28, 2006, and February 28, 2005
 
 
 
2007
  
2006
  
2005
  
 
             
Net revenues
 
$
1,624,074
  
$
1,756,105
  
$
2,525,431
  
Cost of goods sold
   
745,060
    
614,327
    
1,573,116
  
Inventory write down
    
419,765
    
439,188
    
2,088,703
  
 
                   
Gross profit
   
459,249
    
702,590
    
(1,136,388
 ) 
 
               
Operating expenses
                
Engineering, research and development
   
1,048,529
    
1,483,247
    
2,482,668
  
Selling, general, and administrative
   
5,200,393
    
5,867,388
    
6,886,542
  
Legal settlements
   
-
    
267,726
    
2,765,192
  
Impairment losses on long-lived assets
   
-
    
-
    
544,510
  
 
                   
Total operating expenses
    
6,248,922
    
7,618,361
    
14,767,615
 
 
                   
Loss from operations
   
(5,789,673
)
  
(6,915,771
)
  
(13,815,300
)
 
                   
Other income (expense)
              
Impairment of investments
    
-
    
-
    
(286,061
)
Gain on disposition of assets
    
7,750
    
2,446,798
    
-
  
Interest expense, net
    
(392,977
)
  
(6,602,020
)
  
(18,965,852
)
Other income (expense), net
   
6,453
    
(50,000
)
  
166,345
  
Change in derivative liability
    
-
    
16,254,502
    
4,622,235
  
Bankruptcy settlements
    
-
    
1,730,979
    
-
  
 
                   
Total other income (expense)
   
(378,774
)
  
13,780,259
    
(14,463,333
)
 
                   
Net Income (Loss) before Minority interest in subsidiary
   
(6,168,447
)
  
6,864,488
    
(28,278,633
)
Minority interest
   
-
    
-
   
3,970
 
 
                   
Net income (loss) before preferred stock dividend
  
$
(6,168,447
)
$
6,864,488
  
$
(28,274,663
)
Preferred stock dividend
    
-
    
-
    
525,377
  
Net Income (Loss) applicable to common shareholders
  
$
(6,168,447
)
$
6,864,488
  
$
(28,800,040
)
 
                   
Basic and diluted loss per share
  
$
(0.25
)
$
2.24
  
$
(22.35
)
 
                   
Weighted-average shares outstanding
    
25,114,154
    
3,063,216
    
1,288,114
  
 
The accompanying notes are an integral part of these financial statements
 
F-4
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
 
 
 
Preferred Stock Shares
  
Preferred Stock Amount
  
Common
Stock Shares
  
Common
Stock Amount
  
Committed Common
Stock
  
Additional Paid-In Capital
  
Accumulated
Deficit
  
Total Stockholders' Equity (Deficit)
  
 
                                 
                                   
Balance, February 29, 2004
    
591,110
  
$
2,956
    
1,276,056
  
$
127
  
$
3,102,958
  
$
310,336,452
  
$
(317,056,918
)
$
(3,614,425
)
Reclassify prior year warrant expense as liability
    
-
    
-
    
-
    
-
    
-
    
(1,617,403
)
  
-
    
(1,617,403
)
Penalty shares issued on global settlement
    
-
    
-
    
24,116
    
3
    
-
    
292,269
    
-
    
292,272
  
Issuance of Series B for note conversion
    
500,000
    
2,500
    
-
    
-
    
-
    
2,497,500
    
-
    
2,500,000
  
Issuance of Series B for global settlement
    
91,717
    
459
    
-
    
-
    
-
    
458,124
    
-
    
458,583
  
Issuance of Series B creditors settlement
    
290,311
    
1,452
    
-
    
-
    
-
    
1,450,103
    
-
    
1,451,555
  
Series B issued in private placement
    
1,089,245
    
5,446
    
-
    
-
    
-
    
5,440,779
    
-
    
5,446,225
  
Net Loss
    
-
    
-
    
-
    
-
    
-
    
-
    
(28,800,040
)
  
(28,800,040
)
                                                   
Balance, February 28, 2005
    
2,562,383
  
$
12,813
    
1,300,172
  
$
130
  
$
3,102,958
  
$
318,857,824
  
$
(345,856,958
)
$
(23,883,233
)
Series B issued in private placements
    
26,963
    
123
    
-
    
-
    
-
    
123,338
    
-
    
123,461
  
Cancel preferred stock
    
(2,589,346
)
  
(12,936
)
  
-
    
-
    
-
    
(13,903,525
)
  
-
    
(13,916,461
)
Cancel common stock
    
-
    
-
    
(1,300,172
)
  
(130
)
  
(3,102,958
)
  
(305,077,637
)
  
-
    
(308,180,725
)
Stock issued for cancelled common stock
    
-
    
-
    
1,300,172
    
130
    
-
    
308,180,595
    
-
    
308,180,725
  
Stock issued for cancelled preferred stock
    
-
    
-
    
3,319,403
    
332
    
-
    
13,916,129
   
-
    
13,916,461
 
Stock issued for additional claims
   
-
    
-
    
254,127
    
25
    
-
    
856,324
    
-
    
856,349
  
Stock issued in exchange for secured debt
    
-
    
-
    
1,134,000
    
113
    
-
    
2,899,887
    
-
    
2,900,000
  
Stock issued for new money contribution
    
-
    
-
    
3,349,500
    
335
    
-
    
2,952,665
    
-
    
2,953,000
  
Stock issued for DIP financing
    
-
    
-
    
6,065,699
    
607
    
-
    
4,063,411
    
-
    
4,064,018
  
Stock issued for administrative claims
    
-
    
-
    
2,766,786
    
277
    
-
    
(277
)
  
-
    
-
  
Penalty shares issued on new money contribution
    
-
    
-
    
837,375
    
84
    
-
    
(84
)
  
-
    
-
  
Stock issued for unsecured debt
    
-
    
-
    
4,611,247
    
461
    
-
    
8,125,478
    
-
    
8,125,939
  
Stock issued for legal settlements
    
-
    
-
    
644,401
    
64
    
-
    
1,135,501
    
-
    
1,135,565
  
 
                                                  
Issuance of warrants
    
-
    
-
    
-
    
-
    
-
    
943,396
    
-
    
943,396
  
Net Income
    
-
    
-
    
-
    
-
    
-
    
-
    
6,864,488
    
6,864,488
  
Balance, February 28, 2006
    
-
    
-
    
24,282,710
  
$
2,428
    
-
  
$
343,073,025
  
$
(338,992,470
)
$
4,082,983
  
Common stock issued in private placements
    
-
    
-
    
4,412,928
    
442
    
-
    
3,964,714
    
-
    
3,965,156
  
Issuance of warrants
    
-
    
-
    
-
    
-
    
-
    
223,974
    
-
    
223,974
  
Net Loss
    
-
    
-
    
-
    
-
    
-
    
-
    
(6,168,447
)
  
(6,168,447
)
Balance, February 28, 2007
  
 
-
 
  
-
    
28,695,638
  
$
2,870
    
-
  
$
347,261,713
  
$
(345,160,917
)
$
2,103,666
  
 
The accompanying notes are an integral part of these financial statements
 
F-5
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
For the Years Ended February 28, 2007, February 28, 2006 and February 28, 2005
 
 
 
2007
  
2006
  
2005
  
 
  
 
  
 
  
 
  
Cash flows from operating activities
  
 
 
 
 
 
 
Net income (loss)
  
$
(6,168,447
)
$
6,864,488
  
$
(28,800,040
)
Adjustments to reconcile net loss to net cash used in operating activities
              
Depreciation and amortization
   
30,948
    
65,091
    
416,161
  
Gain on disposition of assets
   
(7,750
)
  
(2,446,798
)
  
-
  
Change in allowance for doubtful accounts
   
2,646
    
88,682
    
32,134
  
Change in reserve for inventory obsolescence
   
419,765
    
439,188
    
2,088,703
  
Impairment of long-lived assets and investments
   
-
    
-
    
830,571
  
Gain on extinguishment of debt
   
-
    
(1,730,979
)
  
(17,221
)
Minority interest in net income of consolidated subsidiary
   
-
    
-
    
(3,970
)
Change in derivative liability
    
-
    
(16,254,502
)
  
(4,622,235
)
Beneficial conversion feature on convertible debt
    
-
    
3,801,457
    
19,259,334
  
Operating expense charged for warrants issued
    
223,974
    
943,396
    
-
  
Operating expenses satisfied with note payable
    
167,346
    
-
    
-
  
Operating expenses satisfied with stock
    
-
    
300,000
    
750,855
  
(Increase) decrease in
              
Accounts receivable
   
(164,822
)
  
460,946
    
12,732
  
Inventories
   
214,576
    
302,760
    
895,628
  
Other current assets
   
2,480,700
    
626,467
    
(437,068
)
Other assets
   
-
    
-
    
594,271
  
Increase (decrease) in
              
Accounts payable and accrued expenses
    
(432,452
)
  
1,974,022
    
2,156,666
  
Deferred income
    
-
    
-
    
3,750
  
 
             
Net cash used in operating activities
   
(3,233,516
)
  
(4,565,782
)
  
(6,839,729
)
 
             
Cash flows from investing activities
              
Purchase of property, plant, and equipment
    
(62,796
)
  
-
    
-
  
Proceeds from disposal of property, plant, and equipment
    
7,750
    
-
    
-
  
 
             
Net cash used in investing activities
    
(55,046
)
  
-
    
-
  

F-6
 
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
2007
  
2006
  
2005
  
 
              
Cash flows from financing activities
  
 
 
 
 
 
 
Proceeds from notes payable
    
-
    
-
    
2,150,000
  
Payments on notes payable
    
(97,817
)
  
(103,727
)
  
(778,320
)
Net proceeds from issuance of preferred stock
    
-
    
123,461
    
5,446,225
  
Net proceeds from issuance of common stock
   
3,965,156
    
4,957,154
    
-
  
 
                   
Net cash provided by financing activities
    
3,867,339
   
4,976,888
    
6,817,905
  
 
                   
Net increase in cash and cash equivalents
   
578,777
    
411,106
    
(21,824
)
Cash and cash equivalents, beginning of year
    
472,482
    
61,376
    
83,200
 
 
                   
Cash and cash equivalents, end of year
  
$
1,051,259
  
$
472,482
  
$
61,376
  
 
                   
Supplemental disclosures of cash flow information
              
Interest paid
  
$
46,045
  
$
550,255
  
$
674,383
  
 
                   
Income taxes paid
 
$
-
  
$
-
  
$
-
  
 
Supplemental schedule of non-cash financing and investing activities:
 
During the year ended February 28, 2007 $167,346 of accrued and unpaid interest was added to the principal amount of notes payable.
 
During the year ended February 28, 2006, we:
 
 
·
issued 1,134,000 shares of common stock upon conversion of $2,900,000 of secured debt
 
 
·
issued 2,766,786 shares of common stock for administrative claims arising out of the bankruptcy filing
 
 
·
issued 837,375 shares of common stock as penalty shares for failure to timely file a registration statement
 
 
·
issued 4,611,247 shares of common stock in satisfaction of $8,125,939 of unsecured debt
 
 
·
issued 644,401 shares of common stock as legal settlements
 
During the year ended February 28, 2005, we:
 
 
·
issued 290,311 shares of Series B convertible preferred stock in satisfaction of $ 1,451,555 in liabilities issued 500,000 shares of Series B convertible preferred stock upon conversion of $2,500,000 of note payable
 
The accompanying notes are an integral part of these financial statements
 
F-7
 
 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
NOTE 1 - ORGANIZATION AND OPERATIONS
 
General
 
Aura Systems, Inc., ("Aura" or the "Company") a Delaware corporation, was founded to engage in the development, commercialization, and sales of products, systems, and components, using its patented and proprietary electromagnetic and electro-optical technology. Aura develops and sells AuraGen® mobile induction power systems to the industrial, commercial, and defense mobile power generation markets. In addition, we hold patents for other technologies that have not been commercially exploited.
 
Chapter 11 reorganization
 
On June 24, 2005 we filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code, in the United States Bankruptcy Court, Central District of California, (Case Number LA 05-24550-SB). We secured a Debtor in Possession (“DIP”) loan from Blue Collar Films LLC (“BCF”) for one million dollars and secured an additional $1.2 million DIP loan from AGP Lender LLC. In addition a group of individual investors provided an additional $1.16 million in DIP financing. We submitted a reorganization plan that was approved by the court and voted and approved by the DIP lenders, the secured creditors, the unsecured creditors, the shareholders and the new money investors. Under the reorganization plan (i) the secured creditor retained $2.5 million in a secured note payable over 48 months at 7% annual interest with the first payment starting 12 months after the reorganization, (ii) the Series B Preferred Stock holders received new common shares calculated by dividing the total cash invested in the Series B Placement by $3.37, (iii) the Series A Preferred Stock holders converted their 1.8 Series A Preferred Stock for one new common share, (iv) the common shareholders converted 338 of their shares for one new share, and (v) the DIP loans converted their loans into approximately 6.07 million new shares of common stock, and (vi) all the unsecured creditors received new shares of common stock valued at one share per $1.75 in claim. An additional 5.89 million shares of common stock were issued for the new money and reorganization related fees.254,127 additional shares were issued to shareholders to settle their claims in excess of the bankruptcy court approval.
 
All of the outstanding litigation and disputes were settled during the bankruptcy. The real estate was sold to an unrelated third party in December 2005 for gross proceeds of $8,750,000. After satisfaction of the mortgage liabilities and payment of the costs of the sale, approximately $2.9 million was due us. From this amount, $1.9 million was paid to the minority shareholder, approximately $470,000 was used to satisfy outstanding legal bills, and the balance of $595,000 was received by the Company in March of 2006. All disputes regarding the real estate were settled.
 
We emerged from the Chapter 11 effective January 31, 2006.
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Principles of Consolidation
 
The consolidated financial statements include the accounts of Aura and our subsidiary, Aura Realty, Inc. Investments in affiliated companies are accounted for by the equity or cost method, as appropriate. Significant inter-company amounts and transactions have been eliminated in consolidation.
 
Revenue Recognition
 
The Company’s revenue recognition policies are in compliance with Staff accounting bulletin (SAB) 104. Sales revenue is recognized at the date of shipment to customers when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, no other significant obligations of the Company exist and collectibility is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue.
 
F-8
 
We recognize revenue for product sales upon shipment and when title is transferred to the customer. When Aura performs the installation of the product, revenue and cost of sales are recognized when the installation is complete. We have in the past earned a portion of our revenues from license fees and recorded those fees as income when we fulfilled our obligations under the particular agreement.
 
Comprehensive Income
 
We utilize Statement of Financial Accounting Standards ("SFAS") No. 130, "Reporting Comprehensive Income." This statement establishes standards for reporting comprehensive income and its components in a financial statement. Comprehensive income as defined includes all changes in equity (net assets) during a period from non-owner sources. Examples of items to be included in comprehensive income, which are excluded from net income, include foreign currency translation adjustments and unrealized gains and losses on available-for-sale securities. Comprehensive income is not presented in our financial statements since we did not have any of the items of comprehensive income in any period presented.
 
Cash and Cash Equivalents
 
Cash and equivalents include cash in hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less. We maintain cash deposits at multiple banks located in California. Deposits at each bank are insured by the Federal Deposit Insurance Corporation up to $100,000. We have not experienced any losses in such accounts and believe we are not exposed to any significant risk on cash and cash equivalents.
 
Accounts Receivable
 
Accounts receivable consist primarily of amounts due from customers. We have provided for an allowance for doubtful accounts, which we believe to be sufficient to account for all uncollectible amounts.
 
Inventories
 
Inventories are valued at the lower of cost (first-in, first-out) or market. Due to continuing lower than projected sales, we are holding inventories in excess of what we expect to sell in the next fiscal year. As of February 28, 2007 and February 28, 2006 $3,195,523, and $3,964,864, respectively, of inventories have been classified as long-term assets. (See Note 4.)
 
Property, Plant, and Equipment
 
Property, plant, and equipment, including leasehold improvements, are recorded at cost, less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the respective assets as follows:
 
Buildings
    
40 years
 
Machinery and equipment
    
5 to 10 years
 
Furniture and fixtures
    
7 years
  
 
Improvements to leased property are amortized over the lesser of the life of the lease or the life of the improvements. Amortization expense on assets acquired under capital leases is included with depreciation and amortization expense on owned assets.
 
Maintenance and minor replacements are charged to expense as incurred. Gains and losses on disposals are included in the results of operations.
 
F-9
 
Long-Term Investments
 
We account for all investments where we hold less than a 20% voting interest, cannot exercise significant influence, and where the fair market value of those securities is not readily determinable under the cost basis. Investments in voting interests between 20% and 50% where we can exercise significant influence are accounted for under the equity method of accounting, and investments greater than 50% are generally consolidated for the purposes of financial reporting. As we do not hold a sufficient interest in our investments to exercise significant influence and the fair market value of the investments are not readily determinable, long-term investments have been accounted for under the cost method. A decline in the value of any investment below cost that is deemed other than temporary is charged to earnings. As of February 28, 2007, we have impaired all of our long-term investments.
 
Patents and Trademarks
 
We capitalize the cost of obtaining or acquiring patents and trademarks. Amortization of patent and trademark costs is provided for by the straight-line method over the shorter of the legal or estimated economic life. Amortization expense was $0, $0, and $657,728 for the years ended February 28, 2007, February 28, 2006 and February 28, 2005, respectively. Accumulated amortization was $1,228,061 as of February 28, 2007 and 2006. If a patent or trademark is rejected, abandoned, or otherwise invalidated, the unamortized cost is expensed in that period. During fiscal 2004, we recorded a $2,000,398 long-lived asset impairment charge resulting from the write off of some of our patents and trademarks. We reevaluated our intentions with regard to its patents and trademarks related to products outside our core business and wrote-off the carrying value of patents not related to products in production. In fiscal 2005, due to the continued low sales volume, we wrote off the carrying value of the balance of our patents.
 
Valuation of Long-Lived Assets
 
We review long-lived assets and identifiable intangibles in accordance with SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets," on at least an annual basis or whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. During the year ended February 28, 2005, we recorded asset impairment charges on certain of our long-lived assets (see Note 8).
 
Stock-Based Compensation
 
SFAS No. 123, "Accounting for Stock-Based Compensation," establishes and encourages the use of the fair value based method of accounting for stock-based compensation arrangements under which compensation cost is determined using the fair value of stock-based compensation determined as of the date of grant and is recognized over the periods in which the related services are rendered. The statement also permits companies to elect to continue using the current implicit value accounting method specified in Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," to account for stock-based compensation. We have elected to use the implicit value based method and to disclose the pro forma effect of using the fair value based method to account for its stock-based compensation.
 
If we had elected to recognize compensation expense based upon the fair value at the grant date for awards under this plan consistent with the methodology prescribed by SFAS No. 123, our net loss and loss per share would be reduced to the pro forma amounts indicated below for the years ended February 28, 2007, February 28, 2006 and February 28, 2005:
 
 
 
2007
 
2006
 
2005
 
 
              
Net income (loss), as reported
 
$
(6,168,447
)
$
6,864,488
  
$
(28,800,040
)
Intrinsic value expense
    
-
    
-
    
-
  
Stock-based employee compensation expense determined under fair value presentation for all options
    
-
    
-
    
-
  
 
                    
Pro forma net income (loss)
 
$
(6,168,447
)
$
6,864,488
  
$
(28,800,040
)
 
                    
Basic income (loss) per common share:
              
As reported
 
$
(0.25
)
$
2.24
  
$
(22.35
)
Pro forma
 
$
(0.25
)
$
2.24
  
$
(22.35
)
 
F-10
 
There were no options granted during the years ended February 28, 2005, 2006 and 2007.
 
The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options which do not have vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options.
 
Fair Value of Financial Instruments
 
Our financial instruments include cash and cash equivalents, accounts receivable, and notes receivable, long-term investments, accounts payable, and accrued expenses. The carrying amounts of these instruments approximate their fair value due to their short maturities.
 
Advertising Expense
 
Advertising costs are charged to expense as incurred and were immaterial for the years ended February 28, 2007, February 28, 2006 and February 28, 2005.
 
Research and Development
 
Research and development costs are expensed as incurred. These costs include the expenses incurred in the development of the 200amp ECU, the Tamgen (dual generator), and the eight inch generator.
 
Income Taxes
 
We utilize SFAS No. 109, "Accounting for Income Taxes," which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
 
We have significant income tax net operating losses; however, due to the uncertainty of the realizability of the related deferred tax asset, a reserve equal to the amount of deferred income taxes has been established at February 28, 2007 and February 28, 2006.
 
F-11
 
Loss per Share
 
The consolidated net loss per common share is based on the weighted-average number of common shares outstanding during the year.
 
Estimates
 
The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
 
Major Customers
 
During the year ended February 28, 2007, we conducted business with two customers whose sales comprised 24% of net sales. As of February 28, 2007, two customers accounted for 39 % of net accounts receivable. During the year ended February 28, 2006, we conducted business with four customers whose sales comprised 24% of net sales. As of February 28, 2006, four customers accounted for 87% of net accounts receivable.
 
Recently Issued Accounting Pronouncements
 
In February 2006, FASB issued SFAS No. 155, "Accounting for Certain Hybrid Financial Instruments". SFAS No. 155 amends SFAS No 133, "Accounting for Derivative Instruments and Hedging Activities", and SFAF No. 140, "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities". SFAS No. 155, permits fair value remeasurement for any hybrid financial instrument that contains an embedded derivative that otherwise would require bifurcation, clarifies which interest-only strips and principal-only strips are not subject to the requirements of SFAS No. 133, establishes a requirement to evaluate interest in securitized financial assets to identify interests that are freestanding derivatives or that are hybrid financial instruments that contain an embedded derivative requiring bifurcation, clarifies that concentrations of credit risk in the form of subordination are not embedded derivatives, and amends SFAS No. 140 to eliminate the prohibition on the qualifying special-purpose entity from holding a derivative financial instrument that pertains to a beneficial interest other than another derivative financial instrument. This statement is effective for all financial instruments acquired or issued after the beginning of the Company's first fiscal year that begins after September 15, 2006. The management is currently evaluating the effect of this pronouncement on financial statements.

In March 2006, FASB issued SFAS 156 ‘Accounting for Servicing of Financial Assets’ this Statement amends FASB Statement No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities, with respect to the accounting for separately recognized servicing assets and servicing liabilities. This Statement:

 
1.
Requires an entity to recognize a servicing asset or servicing liability each time it undertakes an obligation to service a financial asset by entering into a servicing contract.
     
 
2.
Requires all separately recognized servicing assets and servicing liabilities to be initially measured at fair value, if practicable.
     
 
3.
Permits an entity to choose ‘Amortization method’ or ‘Fair value measurement method’ for each class of separately recognized servicing assets and servicing liabilities:
     
 
4.
At its initial adoption, permits a one-time reclassification of available-for-sale securities to trading securities by entities with recognized servicing rights, without calling into question the treatment of other available-for-sale securities under Statement 115, provided that the available-for-sale securities are identified in some manner as offsetting the entity’s exposure to changes in fair value of servicing assets or servicing liabilities that a servicer elects to subsequently measure at fair value.
     
 
5.
Requires separate presentation of servicing assets and servicing liabilities subsequently measured at fair value in the statement of financial position and additional disclosures for all separately recognized servicing assets and servicing liabilities.
 
F-12
 
This Statement is effective as of the beginning of the Company’s first fiscal year that begins after September 15, 2006. The management is currently evaluating the effect of this pronouncement on financial statements.

In September 2006, FASB issued SFAS 157 ‘Fair Value Measurements’. This Statement defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements, the Board having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this Statement does not require any new fair value measurements. However, for some entities, the application of this Statement will change current practice. This Statement is effective for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The management is currently evaluating the effect of this pronouncement on financial statements.

In September 2006, FASB issued SFAS 158 ‘Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132(R)’ This Statement improves financial reporting by requiring an employer to recognize the over funded or under funded status of a defined benefit postretirement plan (other than a multiemployer plan) as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through comprehensive income of a business entity or changes in unrestricted net assets of a not-for-profit organization. This Statement also improves financial reporting by requiring an employer to measure the funded status of a plan as of the date of its year-end statement of financial position, with limited exceptions. An employer with publicly traded equity securities is required to initially recognize the funded status of a defined benefit postretirement plan and to provide the required disclosures as of the end of the fiscal year ending after December 15, 2006. An employer without publicly traded equity securities is required to recognize the funded status of a defined benefit postretirement plan and to provide the required disclosures as of the end of the fiscal year ending after June 15, 2007. However, an employer without publicly traded equity securities is required to disclose the following information in the notes to financial statements for a fiscal year ending after December 15, 2006, but before June 16, 2007, unless it has applied the recognition provisions of this Statement in preparing those financial statements:

 
a)
A brief description of the provisions of this Statement
     
 
b)
The date that adoption is required
     
 
c)
The date the employer plans to adopt the recognition provisions of this Statement, if earlier.

The requirement to measure plan assets and benefit obligations as of the date of the employer’s fiscal year-end statement of financial position is effective for fiscal years ending after December 15, 2008. The management is currently evaluating the effect of this pronouncement on financial statements.

In February 2007, FASB issued FASB Statement No. 159, The Fair Value Option for Financial Assets and Financial Liabilities. FASB 159 is effective for fiscal years beginning after November 15, 2007. Early adoption is permitted subject to specific requirements outlined in the new Statement. Therefore, calendar-year companies may be able to adopt FASB 159 for their first quarter 2007 financial statements.

The new Statement allows entities to choose, at specified election dates, to measure eligible financial assets and liabilities at fair value that are not otherwise required to be measured at fair value. If a company elects the fair value option for an eligible item, changes in that item's fair value in subsequent reporting periods must be recognized in current earnings. FASB 159 also establishes presentation and disclosure requirements designed to draw comparison between entities that elect different measurement attributes for similar assets and liabilities.
 
F-13
 
NOTE 3 - INVENTORIES
 
Inventories at February 28, 2007 and February 28, 2006 consisted of the following:
 
 
 
2007
  
2006
  
 
          
Raw materials
  
$
2,939,395
  
$
2,909,930
  
Finished goods
    
4,274,502
    
4,637,685
  
               
 
   
7,213,897
    
7,547,615
  
Reserve for potential product obsolescence
   
(3,268,374
)
  
(2,967,751
)
 
              
 
   
3,945,523
    
4,579,864
  
Non-current portion
    
3,195,523
    
3,964,864
  
 
              
Current portion
  
$
750,000
  
$
615,000
  
 
Inventories consist primarily of components and completed units for the Company’s AuraGen® product.
 
Early in its AuraGen® program, we determined it was most cost-effective to outsource production of components and subassemblies to volume-oriented manufacturers, rather than produce these parts in house. As a result of this decision, and based on then anticipated sales, we purchased, prior to fiscal 2001, a substantial inventory of components at volume prices, most of which was then assembled into finished AuraGen® units. Since sales did not meet such expectations, we have been selling product from this inventory for several years. Management has analyzed its inventories based on its current business plan, current orders for future delivery, and pending proposals with prospective customers and has determined we do not expect to realize all of its inventories within the next year. The net inventories as of February 28, 2007 and February 28, 2006, which are not expected to be realized within a 12-month period have been reclassified as long term.
 
We assessed the net realizability of these assets, and the potential obsolescence of inventory. In accordance with this assessment, management has recorded a reserve of $3,268,374 and $2,967,751 at February 28, 2007 and February 28, 2006, respectively.
 
NOTE 4 - PROPERTY, PLANT, AND EQUIPMENT
 
Property, plant, and equipment at February 28, 2007 and February 28, 2006 consists of the following:
 
   
2007
 
2006
 
 
          
Machinery and equipment
   
903,017
    
911,308
  
Furniture and fixtures
   
1,399,636
    
1,509,492
  
 
   
2,302,653
    
2,420,800
  
Less accumulated depreciation and amortization
   
2,244,136
    
2,394,131
  
Property, plant and equipment, net
 
$
58,517
  
$
26,669
  
 
Depreciation and amortization expense was $30,948, $65,091, and $416,161 for the years ended February 28, 2007, February 28, 2006 and February 28, 2005, respectively.
 
F-14
 
In December 2005, our majority owned subsidiary, Aura Realty, sold the buildings we operate in to an unrelated third party for gross proceeds of $8,750,000. After satisfaction of the mortgage liabilities and payment of the costs of the sale, approximately $2.9 million was due us. From this amount, $1.9 million was paid to the minority shareholder, approximately $470,000 was used to satisfy outstanding legal bills, and the balance of $595,000 was received by the Company in March of 2006. We then entered into a lease arrangement with the purchasers to lease one of the properties for a period of two years beginning January 1, 2006.
 
NOTE 5 - LONG-TERM INVESTMENTS
 
We have made long-term investments in the common stock of three companies as follows: Aquajet-$923,835; Algo Technology-$1,348,652 and Telemac-$715,153. As of February 29, 2004, we had fully written off our investment in Aquajet and Algo Technology, and had a net book value in our Telemac investment of $286,061. During fiscal 2005, we wrote off the balance of our investment in Telemac and as of February 28, 2007 and 2006, we have fully written off all our long-term investments.
 
NOTE 6 - NOTES PAYABLE
 
Notes payable at February 28, 2007 and 2006 consisted of the following:
 
 
 
2007
  
2006
  
 
          
Note payable (a)
  
$
2,594,529
  
$
2,525,000
  
Less current portion
   
611,411
    
48,766
  
Long-term portion
  
$
1,983,118
  
$
2,476,234
  
 
(a) Represents notes payable dated January 31, 2006, bearing interest at a rate of 7% per annum and secured by our intellectual property. The notes carry a term of five years with interest accruing the first twelve months, principal and interest payments beginning the thirteenth month, and continuing through month sixty. During the year ended February 28, 2007, $167,346 in accrued and unpaid interest was added to the principal balance of the notes.
 
Future maturities of notes payable at February 28, 2007 are as follows:
 
Year Ending February 28,
  
 
 
2008
  
$
611,411
  
2009
    
655,610
  
2010
    
703,004
  
2011
    
624,504
  
Total
  
$
2,594,529
  
 
F-15
 
NOTE 7 - ACCRUED EXPENSES
 
Accrued expenses at February 28, 2007 and February 28, 2006 consisted of the following:
 
 
 
2007
  
2006
 
 
          
Accrued payroll and related expenses
 
$
324,636
  
$
178,170
  
Accrued interest
          
16,833
  
Other
   
145,456
    
333,189
  
Total
 
$
470,092
  
$
528,192
  
 
NOTE 8 - COMMITMENTS AND CONTINGENCIES
 
Leases
 
At February 28, 2007, we did not have any significant long-term operating leases. Rent expense charged to operations amounted to $268,380, $858,368, and $838,458 for the years ended February 28, 2007, February 28, 2006 and February 28, 2005, respectively.
 
Litigation
 
Barovich/Chiau et. al. v. Aura Systems, Inc. et. al. (Case No. CV -95-3295).
 
As previously reported in our fiscal 2000 report on Form 10-K, we settled shareholder litigation in the referenced matter in January 1999. On November 20, 1999, the parties entered into an Amended Stipulation of Settlement, requiring that we make payment of $2,260,000 (plus interest) in thirty-six equal monthly installments of $70,350. On October 22, 2002, after we had failed to make certain monthly payments, Plaintiffs applied for and obtained a judgment against us for $935,350, representing the balance due. We have subsequently made only two monthly payments of $70,350 each, reducing the amount owed to $794,650 (plus interest) as of February 28, 2005. Subsequent to year end, the bankruptcy court (see footnote 18) approved the settlement of this claim in the amount of approximately $820,000 as an unsecured claim, to be satisfied by the issuance of approximately 465,000 shares of common stock in the recapitalized company. Plaintiffs appealed the settlement claiming they are a secured creditor entitled to full payment in cash over a period of five years. The appellate court upheld the settlement provisions, and Plaintiffs have appealed this decision. The appeal is pending.
 
NOTE 9 - STOCKHOLDERS' EQUITY
 
During the year ended February 28, 2005, we issued 1,971,273 shares of Series B:
 
1,089,245 of these shares were issued for cash totaling $5,446,225
 
500,000 of these shares were issued in conversion of $2,500,000 of notes payable
 
91,717 of these shares were issued as part of the global settlement totaling $458,583
 
290,311 of these shares were issued in settlement of liabilities totaling $1,451,555
 
During the year ended February 28, 2006, we issued 26,963 shares of Series B Preferred Stock for consideration of $123,461.
 
As part of the reorganization plan, all Series A and Series B Preferred Stock was converted into common stock of the reorganized company. As of February 28, 2007, there is no outstanding preferred stock.
 
F-16
 
Common Stock
 
At February 28, 2007, 2006 and 2005, we had 50,000,000 shares of $0.0001 par value common stock authorized for issuance. During the years ended February 28, 2007 and 2006, we issued 4,412,928 and 24,282,710 shares of common stock, respectively.
 
In the year ended February 28, 2007, we issued 4,412,928 shares of common stock for net proceeds of $3,965,156.
 
In the year ended February 28, 2006, we issued 24,282,710 shares of common stock as follows:
 
 
·
1,134,000 shares upon conversion of $2,900,000 of secured debt
 
 
·
2,766,786 shares for administrative claims arising out of the bankruptcy filing
 
 
·
837,375 shares as penalty shares for failure to timely file a registration statement
 
 
·
4,611,247 shares in satisfaction of $8,125,939 of unsecured debt
 
 
·
1,300,172 shares in exchange for the old common stock
 
 
·
3,319,403 shares for cancelled preferred stock
 
 
·
254,127 additional shares to settle claims in excess of the bankruptcy approval
 
 
·
644,401 issued for legal settlements
 
 
·
6,065,699 shares for DIP financing
 
 
·
 3,349,500 shares for new money contribution
 
As described below, as of February 28, 2005 we had commitments to issue, in exchange for consideration already received, approximately 65,000 shares of common stock.
 
During the year ended February 28, 2005, we issued 24,116 common shares as penalty shares on the shares purchased in the real estate transaction, for failure to file a registration statement.
 
Director Stock Options
 
We have granted nonqualified stock options to certain directors. Options were granted at fair market value at the date of grant, vested immediately, and were exercisable at any time within a 10-year period from the date of grant. These options were cancelled as part of the Reorganization Plan as of February 28, 2006.
 
A summary of our outstanding options and activity under the director’s plan is as follows:
 
   
Number of Shares
  
Weighted-Average Exercise Price
  
Outstanding, February 28, 2005
   
1,331
 
$
696.28-777.40
  
Exercisable, February 28, 2005
   
1,331
 
$
696.28-777.40
  
Cancelled, February 28, 2006
    
(1,331
)
$
696.28-777.40
  
Outstanding, February 28, 2006
   
0
        
 
Employee Stock Options
 
The 1989 Stock Option Plan has granted the maximum allowable number of options authorized. In March 2000, our Board of Directors adopted the 2000 Stock Option Plan, a non-qualified plan which was subsequently approved by the stockholders. The 2000 Stock Option Plan authorized the grant of options to purchase up to 10% of our outstanding common shares.
 
Options issued to employees and employee directors were issued with an exercise price equal to the fair market value of our common stock and the value of options, as determined by the Black-Scholes model, of consultant options was not material.
 
F-17
 
As part of the reorganization plan, all outstanding employee options in both plans were cancelled.
 
Activity in the employee stock option plans was as follows:
 
 
  
1989 Plan
  
2000 Plan
  
 
 
Number of Shares
  
Weighted-Average Exercise Price
  
Number of Shares
  
Weighted-Average Exercise Price
  
 
                  
Outstanding, February 28, 2004
   
2,112
  
$
605.02-2,470.78
    
163,906
  
$
16.90-216.32
  
Exercisable, February 28, 2004
   
2,112
 
$
605.02-2,470.78
    
155,428
  
$
16.90-216.32
  
Outstanding, February 28, 2005
    
2,112
  
$
605.02-2,470.78
    
163,906
  
$
16.90-216.32
  
Exercisable, February 28, 2005
    
2,112
  
$
605.02-2,470.78
    
155,428
  
$
16.90-216.32
  
Cancelled
    
(2,112
)
$
605.02-2,470.78
    
(163,906
)
$
16.90-216.32
  
Outstanding, February 28, 2006
    
0
  
$
-
    
0
  
$
0
  
 
The exercise prices for the options outstanding at February 28, 2006, and information relating to these options is as follows:
 
Range of Exercise Prices
  
Stock Options Outstanding
 
Stock Options Exercisable
 
Weighted-Average Remaining Contractual Life
 
Weighted-Average Exercise Price of Options Outstanding
 
Weighted-Average Exercise Price of Options Exercisable
None
                    
 
Warrants
 
As of February 29, 2005, the aggregate number of outstanding options, warrants, and common share equivalents was significantly in excess of the authorized but unissued number of shares of our common stock. Management intended to seek shareholder approval of an increase in the Company’s authorized shares sufficient to satisfy all existing commitments and create available shares for potential future investments. However, such approval was not granted. Hence, management determined that the value of the warrants was required to be classified as a liability under the provisions of EITF 00-19 - Accounting for Derivative Financial Instruments Indexed To and Potentially Settled In a Company’s Own Stock. As of February 28, 2005, the value of the warrants has been classified as a liability.
 
Activity in issued and outstanding warrants was as follows:
 
   
Number of Shares
  
Exercise Prices
  
Outstanding, February 29, 2004
    
130,909
  
$
16.90-858.52
  
Issued
    
443,786
  
$
6.76-16.90
  
Exercised
    
-
    
-
  
Expired
    
-
    
-
  
Outstanding, February 28, 2005
    
574,684
  
$
6.76-858.52
  
Cancelled
    
(574,684
)
$
6.76-858.52
  
Issued
    
5,022,948
  
$
2.00-3.00
  
Outstanding, February 28, 2006
    
5,022,948
  
$
3.50
  
Issued
    
1,155,589
  
$
2.00-3.00
  
Outstanding, February 28, 2007
    
6,178,537
  
$
2.00-3.50
  
 
F-18
 
As part of the reorganization plan, all warrants outstanding as of January 31, 2006 were cancelled.
 
During the year ended February 28, 2007, we issued 1,155,589 warrants with exercise prices ranging from $2.00 to $3.00, and vesting periods of three to five years.
 
During the year ended February 28, 2006, we issued 5,022,945 warrants with a grant date of January 31, 2006, as part of the reorganization plan. The warrants are exercisable for a period of five years from the date of grant and are exercisable at a price of $3.00 the first twelve months, $3.50 the second twelve months, and $4.00 thereafter.
 
The exercise prices for the warrants outstanding at February 28, 2007, and information relating to these warrants is as follows:
 
Range of Exercise Prices
  
Stock Warrants Outstanding
 
Stock Warrants Exercisable
 
Weighted-Average Remaining Contractual Life
 
Weighted-Average Exercise Price of Warrants Outstanding
 
Weighted-Average Exercise Price of Warrants Exercisable
  
 
Intrinsic Value
$3.50
  
5,022,945
  
5,022,945
  
47 months
  
$3.50
  
$3.50
  
$0.00
$2.00-$3.00
  
1,155,589
  
  893,089
  
59
  
$2.71
  
$2.80
  
$0.00
 
 NOTE 10 - INCOME TAXES
 
We have not incurred any income tax expense since inception. The actual tax benefit differs from the expected tax benefit computed by applying the United States federal corporate tax rate of 34% to loss before income taxes as follows for the years ended February 28, 2007 and February 28, 2006 and February 28, 2005:
 
 
 
2007
 
2006
 
2005
  
 
              
Expected tax benefit
   
34.0
%
  
34.0
%
  
34.0
%
State income taxes, net of federal benefit
   
6.0
    
6.0
   
6.0
 
Changes in valuation allowance
   
(40.0
)
  
(40.0
)
  
(40.0
)
Total
    
-
%
  
-
%
  
-
%
 
The following table summarizes the significant components of our deferred tax asset at February 28, 2007 and February 28, 2006:
 
 
 
2007
 
2006
 
Deferred tax asset
 
 
 
 
 
Net operating loss carryforward
   
119,900,000
    
115,500,000
  
Valuation allowance
   
(119,900,000
)
  
(115,500,000
)
Net deferred tax asset
 
$
-
  
$
-
  
 
We recorded an allowance of 100% for its net operating loss carryforward due to the uncertainty of its realization.
 
A provision for income taxes has not been provided in these financial statements due to the net loss. At February 28, 2007, we had operating loss carryforwards of approximately $299,600,000, which expire through 2022.
 
F-19
 
NOTE 11 - EMPLOYEE BENEFIT PLANS
 
We sponsor two employee benefit plans: The Employee Stock Ownership Plan (the "ESOP") and a 401(k) plan.
 
The ESOP is a qualified discretionary employee stock ownership plan that covers substantially all employees. We did not make any contributions to the ESOP during the years ended February 28, 2007, February 28, 2006 and February 28, 2005.
 
We sponsor a voluntary, defined contribution 401(k) plan. The plan provides for salary reduction contributions by employees and matching contributions by us of 20% of the first 7% of the employees' pre-tax contributions. The matching contributions included in selling, general, and administrative expenses were $8,196, $10,552 and $17,863 for the years ended February 28, 2007, February 28, 2006 and February 28, 2005, respectively.
 
NOTE 12 - SEGMENT INFORMATION
 
We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia. All of our operating long-lived assets are located in the United States. We operate in one segment.
 
Total net revenues from customer geographical segments are as follows for the years ended February 28, 2007 and February 28, 2006 and February 28, 2005:
 
   
2007
 
2006
 
2005
 
 
              
United States
 
$
1,416,145
  
$
1,583,509
  
$
2,420,136
  
Canada
   
198,737
    
105,243
    
43,523
  
Europe
   
4,948
    
7,246
    
7,826
  
Asia
   
4,244
    
60,107
    
53,946
  
 
                    
Total
 
$
1,624,074
  
$
1,756,105
  
$
2,525,431
  
 
NOTE 13 - QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
 
The following tables list our quarterly financial information for the years ended February 28, 2007, February 28, 2006 and February 28, 2005:
 
2007
  
 
 
First
Quarter
  
Second Quarter
 
Third
Quarter
 
Fourth Quarter
 
Total
Year
  
 
                      
Net revenues
 
$
244,462
  
$
591,898
  
$
354,109
  
$
433,605
  
$
1,624,074
  
Gross profit
 
$
13,306
  
$
400,010
  
$
145,098
  
$
(99,165
 ) 
$
459,249
  
Loss from operations
 
$
(1,434,293
)
$
(1,347,389
)
$
(1,443,631
)
$
(1,564,360
)
$
(5,789,673
)
Net loss
 
$
(1,455,780
)
$
(1,377,724
)
$
(1,652,910
)
$
(1,682,033
)
$
(6,168,447
)
Basic and diluted loss per share
 
$
(0.06
)
$
(0.06
)
$
(0.06
)
$
(0.07
)
$
(0.25
)
 
F-20

2006
 
 
First
Quarter
  
Second Quarter
 
Third
Quarter
 
Fourth Quarter
 
Total
Year
  
 
                      
Net revenues
 
$
530,703
  
$
274,007
  
$
574,231
  
$
377,164
  
$
1,756,105
  
Gross profit
 
$
335,651
  
$
171,949
  
$
395,431
  
$
(200,441
 ) 
$
702,590
  
Loss from operations
 
$
(1,249,927
)
$
(1,237,150
)
$
(1,143,838
)
$
(3,284,856
)
$
(6,915,771
)
Net income (loss)
 
$
(5,262,942
)
$
18,445,502
  
$
(1,418,084
)
$
(4,751,380
)
$
6,864,488
  
Basic and diluted income (loss) per share
 
$
(4.06
)
$
13.52
  
$
(1.09
)
$
(6.13
)
$
2.24
  
 
2005
 
 
First
Quarter
 
Second Quarter
 
Third
Quarter
 
Fourth Quarter
 
Total
Year
  
 
                      
Net revenues
 
$
685,834
  
$
599,443
  
$
631,774
  
$
608,380
  
$
2,525,431
  
Gross profit
 
$
416,836
  
$
470,024
  
$
377,300
  
$
(2,400,548
)
$
(1,136,388
)
Loss from operations
 
$
(1,491,525
)
$
(3,810,130
)
$
(2,024,533
)
$
(5,664,112
)
$
(13,815,300
)
Net loss
 
$
(2,571,476
)
$
(11,690,737
)
$
(16,504,722
)
$
1,966,895
  
$
(28,800,040
)
Basic and diluted loss per share
 
$
(2.03
)
$
(9.13
)
$
(12.84
)
$
3.43
  
$
(22.35
)
 
F-21
 
SUPPLEMENTAL INFORMATION
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
To the Board of Directors and Stockholders
 
Aura Systems, Inc. and subsidiaries
 
Our audits were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) and were made for the purpose of forming an opinion on the basic consolidated financial statements taken as a whole. The consolidated supplemental schedule II is presented for purposes of complying with the Securities and Exchange Commission's rules and is not a part of the basic consolidated financial statements. This schedule has been subjected to the auditing procedures applied in our audits of the basic consolidated financial statements and, in our opinion, is fairly stated in all material respects in relation to the basic consolidated financial statements taken as a whole.

/s/ Kabani & Company, Inc.
Certified Public Accountants

Los Angeles, California
September 12, 2007
 
F-22
 
 
VALUATION AND QUALIFYING ACCOUNTS - SCHEDULE II
 
 
 
Balance, Beginning of Year
 
Additions charged to Operations
 
Deductions
from
Reserve
 
Balance,
End of
Year
  
Reserve for doubtful accounts (see Note 3 and 6)
  
February 28, 2007
  
$
164,241
  
$
-
  
$
-
  
$
164,241
  
February 28, 2006
  
$
2,220,474
  
$
-
  
$
2,056,233
  
$
164,241
  
February 28, 2005
  
$
2,188,340
  
$
86,537
  
$
54,403
  
$
2,220,474
  
Reserve for obsolete inventories (see Note 5)
February 28, 2007
  
$
2,967,751
  
$
300,623
  
$
-
  
$
3,268,374
  
February 28, 2006
  
$
4,038,047
  
$
-
  
$
1,070,296
  
$
2,967,751
  
February 28, 2005
  
$
2,032,000
  
$
2,006,047
  
$
-
  
$
4,038,047
  
Reserve for investment (see Note 8)
February 28, 2007
  
$
2,987,640
  
$
-
  
$
-
  
$
2,987,640
  
February 28, 2006
  
$
2,987,640
  
$
-
  
$
-
  
$
2,987,640
  
February 28, 2005
  
$
2,701,579
  
$
286,061
  
$
-
  
$
2,987,640
  
 
F-23